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Patterning of vertebrate melanophores is essential for mate selection and 
protection from UV-induced damage. Patterning can be influenced by 
circulating long-range factors, such as hormones, but it is unclear how their 
activity is controlled in recipient cells to prevent excesses in cell number and 
migration. The zebrafish wanderlust mutant harbors a mutation in the 
sheddase bace2 and exhibits hyperdendritic and hyperproliferative 
melanophores that localize to aberrant sites. We performed a chemical screen 
to identify suppressors of the wanderlust phenotype and found that inhibition 
of insulin/PI3Kg/mTOR signaling rescues the defect. In normal physiology, 
Bace2 cleaves the insulin receptor, whereas its loss results in hyperactive 
insulin/PI3K/mTOR signaling. Insulin B, an isoform enriched in the head, 
drives the melanophore defect.  
 
Melanoma is malignant skin cancer derived from transformed melanocytes. 
Bace2 also negatively regulates melanoma cell proliferation and affects 
morphology. Loss of Bace2 leads to early onset tumors with migratory and 
invasive phenotype. These results suggest that signaling from a long-distance 
factor, insulin, can be negatively regulated by a melanophore-specific 
expression of a sheddase and melanoma cells utilize this mechanism to 
regulate tumor cell progression. 
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 1 
CHAPTER 1: INTRODUCTION 
1.1 Vertebrate pigmentation development 
1.1.1 Background 
Pigment patterning has been a long-term attraction for both non-scientists and 
scientists. The complex combination of melanin in the butterfly, versatile fish 
stripe in the aquarium and beautiful fur colors in a running leopard have 
intrigued many people. Evolutionary biologists have been studying pigment 
patterning as one of the most striking features to observe across species, as 
mutations in pigmentation usually have limited impact on survival but can co-
evolve with other traits. Behavioral ecologists are fascinated by the fact that 
animals use their pigment patterning in mate selection, relative recognition and 
camouflage. Developmental biologists have used pigment as a model system 
to study the general problem of pattern formation and regenerative biology 
(Kelsh et al., 2009; Parichy, 2003). Geneticists study the genes and pigment 
cells that are responsible for regulating pigment cells specification, migration 
and survival.  
 
Pigment patterning is defined by combinations of pigment cells that organize 
themselves on either epidermis or endoderm in animals and together display a 
recognizable colorful pattern for each species (Kelsh et al., 2009). The 
purpose of this section is to review vertebrate pigmentation, with a focus on 
the ontogenic development of melanocytes, which are the black pigment cells 
in vertebrate. Then this section will discuss pigmentary diseases, highlighting 
the importance of understanding pigment patterning from a therapeutic 
perspective. In the end, this section will examine the cell intrinsic and 
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environmental factors regulating pigment cell development.   
  
1.1.2 Ontogenetic development of melanocytes 
Overview 
Melanocytes are the black pigment cells that are responsible for producing 
melanin. In human skin, melanocytes reside in the border between epidermis 
and dermis, accounting for the black pigmentation in the hairs, skins and eyes 
(Goding, 2007). Each melanocyte is connected to the neighboring 
keratinocytes in the overlying epidermis and to the fibroblasts in the underlying 
basal layer (Figure 1). Human skin is mainly comprised of those three types of 
cells, which are highly collaborative and all together regulate skin function and 
appearance (Yamaguchi et al., 2007). 
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Figure 1. Human skin is composed of keratinocytes, melanocytes and 
fibroblasts. Right side is light-pigmented skin and Left side is dark-pigmented 
skin. Melanin granule number and content regulate skin color. From top to 
bottom: SC, stratum corneum; G, stratum granulosum; S, stratum spinosum; 
B, stratum basale; BM, basement membrane; D, dermis. Cell types: K, 
keratinocyte; M, melanocyte; F, fibroblast; shaded oval, melanin granule. 
Figure adapted from (Yamaguchi et al. 2007). 
 
Melanocytes are derived from neural crest 
Melanocytes are originated from neural crest cells and migrate to the junction 
between epidermis and dermis, as well as to the hair follicles (Thomas and 
Erickson, 2008). Neural crest cells are a pluripotent cell population unique to 
vertebrates that originates in the neural tube. Neural crest cells undergo 
extensive migration during epithelial to mesenchymal transition and 
differentiate into various structures including pigmented melanocytes in the 
skin (Figure 2) (Sommer, 2011). Melanocytes lineage specification is regulated 
in both spatial and temporal manners. In a traditional view, the melanocyte 
lineage is specified early on during neural crest development, as melanoblasts 
(the melanocytes precursor cells) has a fixed lineage program as soon as they 
are spatially separated from the other neural crest lineages (Sommer, 2011). 
Melanoblasts migrate on a dorsolateral pathway between the ectoderm for 
mice and avians (Thomas and Erickson, 2008), or on both dorsolateral and 
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ventral pathways in the case of zebrafish (Kelsh et al., 2009). Recently work 
has also suggested a dual neural crest origin of melanocytes, one is derived 
from neural crest cells by dorsolateral migration, and the other one is 
originated from a Schwann cell (glial)/melanoblast progenitor by ventral 
migration (Mort et al., 2015).   
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Figure 2. Neural crest cells differentiate into various progenity lineages, 
regulated by different combinations of transcription factors. Melanocyte 
lineage is specified by SOX10 and MITF. Figure adapted from (Sauka-
Spengler and Bronner 2010). 
 
The main function of melanocytes is to produces melanin 
The maturation of melanocytes is marked by a process called melanogenesis, 
whereby melanocytes synthesize a group of pigmentation enzymes and 
structural proteins to reach a maturation structure and produce melanin within 
an intracellular organelle named the melanosome. The critical melanogenic 
enzymes include tyrosinase (TYR), tyrosinase related protein 1 (TYRP1), and 
DOPAchrome tautomerase (DCT) (Goding, 2007).They catalyze biochemical 
reactions to synthesize melanin starting from the substrate by hydroxylating 
tyrosine. Melanocytes can make two different types of melanin, which are 
yellow/red soluble pheomelanin (predominantly for individuals with red skins 
and skin, in whom skin cancer is more frequently observed) and dark 
brown/black insoluble eumelanin (the major pigment in individuals with dark 
skin and hair and is more efficient in UV protection) (Figure 3) (Ebanks et al., 
2009). The key structural proteins include PMEL (Hellström et al., 2011; 
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McGlinchey et al., 2009) and MART1 (De Mazière et al., 2002; Hoashi et al., 
2005), both of which are critical for melanosome to reach a maturation 
structure. PMEL is proteolytically cleaved into small fragments, and  those 
fragment then polymerize and form a fibrillar matrix inside the melanosome to 
allow melanin deposition and melanosome structure. MART1 forms a complex 
with PMEL inside melanocytes and is critical for PMEL expression and 
processing. 
 
 
Figure 3. Melanin synthesis scheme. Melanin-making enzymes utilize 
tyrosine as a substrate to make two types of polymer of melanin in human: 
eumelanin (black-brown) and pheomelanin (yellow-red). Figure adapted from 
(Cichorek et al. 2013). 
 
Melanocytes transfer melanin to keratinocytes through dendrites  
Mature melanocytes secrete melanin-containing melanosome to 30~40 
neighboring keratinocytes. Keratinocytes ingest the melanosome to form an 
umbrella structure around their nucleus to protect against UV-induced damage 
(Yamaguchi et al., 2007) (Figure 4). Therefore, melanins in both melanocytes 
 7 
(a sparse cell population) and the upper layer keratinocytes together constitute 
the skin color.  
 
Melanosome delivery is carried out by a specialized melanocyte cell projection 
called dendrites. Dendrites are actin and microtubule containing structures and 
their formation is regulated by keratinocyte-secreted growth factors and 
peptide hormones especially under UV stimulation (Kippenberger et al., 1998). 
Even though the exact molecular basis for dendrite formation is not known, the 
growth factors and peptide hormones generally converge on the cAMP second 
messenger pathway, and protein kinase C and MAP kinase pathway inside 
melanocytes (Hara et al., 1995; Hirobe, 1978). Small GTP-binding proteins 
such as Rac and Rho are known to regulate melanocyte dendrite formation, 
through a fine-tuned balance between Rho (which stimulates dendrite 
retraction) and Rac (which stimulates dendrite formation) (Scott, 2002), similar 
to what occurs in neuronal cells. Dendricity and pigmentation are the two key 
hallmarks for melanocyte differentiation. However, unlike pigmentation, how 
dendrites are acquired in concert with melanocyte differentiation during 
development is poorly understood.  
 8 
 
  
 
Figure 4. Melanocytes extend dendrites to transfer melanin pigment 
(inside melanosomes) to neighboring keratinocytes. Melanins form an 
umbrella shape around the keratinocyte nucleus to protect them from UV-
induced damage. Figures adapted from 2012 Pearson Education. 
 
Pigment diseases 
Human pigment disorders highlight the importance of understanding pigment 
biology and has triggered an extensive search for therapeutic opportunities. 
Vitiligo is a hypopigmentation disorder characterized by patches of the skin 
losing their pigment. Vitiligo patients do not have functional melanocytes and 
multiple mechanism might contribute to this loss, with autoimmune disease 
triggering genetic susceptibility thought to be the main one (Picardo et al., 
2015). Waardenburg syndrome is another hypopigmentation disease with loss 
of pigmentation in skin patches and deafness. It is an autosomal dominant 
disorder with mutations of genes required for the melanocyte development 
pathway (such as EDN3, EDNRB, MITF, PAX3, SNAI2, and SOX10 ) 
(Bondurand et al., 2000; Edery et al., 1996; Tassabehji et al., 1994). Patients 
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do not have melanocytes and have pigment defects in the skin, hair, eyes and 
problems with hearing. Albinism is a congenital disorder with patients are 
complete or partial lack of pigment in the skin, hair and eyes and are 
experiencing problematic vision. In the most severe form, Type 1 
(oculocutaneous) albinism there is an absence of tyrosinase (the key enzyme 
making melanin) due to a mutation in TYR gene (Oetting and King, 1999). 
Albinism patients have melanocytes but are not able to produce melanin. 
Finally, melanoma is an extreme example of a pigment disorder where 
melanocytes are transformed because of oncogenic mutations and become 
malignant (Bandarchi et al., 2010). Melanoma will be discussed extensively in 
chapter 3.1. 
     
1.1.3 Cell intrinsic mechanisms of melanocyte development 
Melanocyte specification 
Neural crest cells give rise to melanocytes, during which a tightly-regulated 
cell intrinsic program is activated to ensure proper cell specification. 
Microphthalmia-associated transcription factor (MITF) is the master 
transcription factor that has pleiotropic effects in melanocyte specification, 
differentiation and survival. MITF marks melanoblasts as soon as neural crest 
cell emigration from the neural tube (Hou and Pavan, 2008). Mutations in 
MITF are the cause of many pigment disease such as Waardenburg syndrome 
(Sun et al., 2017). Mice with MITF mutation display severe reduction of the 
early melanocyte marker DCT (Nakayama et al., 1998), while zebrafish with 
MITF loss of function fail to develop melanocytes (Lister et al., 1999). These 
all together suggest MITF plays a critical role in melanocyte specification. 
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But what factors activate MITF to pave the road for melanocytes? It was 
shown that PAX3 (Bondurand et al., 2000) and SOX10 (Lee et al., 2000) act 
synergistically to bind to the MITF promoter and activate MITF transcription in 
neural crest cells, with SOX10 being the major player (Elworthy et al., 2003) 
(Figure 5). Mice null for SOX10 have absence of melanocyte markers MITF 
and DCT in the dorsolateral pathway (Britsch et al., 2001), while PAX3 null 
leads to greatly reduced number of DCT+ melanocytes. These data suggests 
that SOX10 directly regulates MITF expression while PAX3 collaborates with 
these process during early melanoblast expansion (Hornyak et al., 2001). 
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Figure 5. Melanocyte development is regulated by several key signaling 
pathways. Three major signaling pathways (WNT, KIT, and EDNRB) are 
stimulators to activate Mitf. Mitf subsequently transcriptionally turns on target 
genes, which include genes involved in cell survival,  cell proliferation and 
differentiation. Figure adapted from (Hou and Pavan 2008). 
 
However, glial cells can also co-express SOX10 and PAX3. What additional 
factor helps distinguish melanoblasts? Forkhead transcription factor FOXD3 
has been shown to serve as negative regulator of the melanocyte lineage by 
repressing MITF expression. FOXD3 is expressed in all neural crest cells 
except for cells destined for the melanocytic lineage (Kos et al., 2001). In 
addition, overexpression of FOXD3 in quail neural crest cell cultures leads to 
glial cells while inhibiting melanocyte marker expression (Thomas and 
Erickson, 2009). In zebrafish, neural crest cells give rise to three different 
types of pigment cells: melanophores (fish orthologue of melanocytes), 
iridophores and xanthophores. Enforced expression of foxd3 in pigment 
progenitors represses mitfa expression and induces iridophores generation in 
zebrafish (Curran et al., 2009; Ignatius et al., 2008), while in mice FOXD3 is 
contributing to glia and neurons cell fate. These together suggested an 
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elegant network where SOX10 and PAX3 activate MITF expression to prompt 
melanocytes specification and FOXD3 negatively inhibits this process. 
 
Melanocytes differentiation 
Differentiated melanocytes synthesize melanin and acquire dendritic cell 
morphology. Melanocytes pigmentation is regulated via the cell intrinsic factor 
MITF. MITF directly activates numerous targets that are important for 
melanocytes differentiation. These include genes encoding melanin synthesis 
enzymes, such OA1 (Vetrini et al., 2004), TYR, and TYRP1 (Lowings et al., 
1992) and DCT (Schwahn et al., 2005); genes important for melanosome 
maturation, such as PMEL and MART1 (Du et al., 2003). What factors serve 
as the cue to activate MITF to trigger melanocyte differentiation? Pro-
opiomelanocortin (POMC) is a precursor polypeptide that is produced in 
keratinocytes and cleaved into the small peptides α-MSH and ACTH (Paus et 
al., 1999; Tsatmali et al., 2000). In response to UV stimulation, keratinocytes 
secrete α-MSH (α-MSH can also be secreted systematically by the anterior 
pituitary gland) (Schauer et al., 1994) and α-MSH subsequently binds to the 
melanocortin 1 receptor (MC1R), a G protein–coupled receptor expressing on 
melanocyte cell membrane through paracrine signaling (Mountjoy et al., 1992). 
Agonist-bound MC1R activates adenylyl cyclase and the second messenger 
cAMP, which leads to phosphorylation of cAMP responsive-element-binding 
protein (CREB). CREB then transcriptionally activates MITF (Figure 5). MITF 
expression is enriched significantly within one day of UV exposure, while the 
downstream transcriptional targets such as TYR, PMEL, and DCT respond 
within 1–3 weeks after UV exposure (Levy et al., 2006; Videira et al., 2013). 
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Melanocyte pigmentation in response to UV exposure therefore can take 
several days to weeks to occur. 
 
Melanocyte migration          
Melanocytes are highly migratory populations, with KIT and endothelin 
receptor type B (EDNRB) playing vital roles during these process. KIT is 
known as stem cell growth factor receptor and it is highly expressed in both 
melanoblast and melanocytes (Wehrle-Haller, 2003). Zebrafish with KIT null 
mutations have defective melanocyte migration and subsequently undergo 
apoptosis. Mice with KIT mutation or KIT ligand mutation leads to a dominant 
white spotting (W) or Steel (Sl) phenotype with absence of melanocytes 
(Cable et al., 1995; Geissler et al., 1988; Wehrle-Haller, 2003).  
 
EDNRB and its ligand EDN3 are required for melanoblast proliferation and 
migration in the dermis. Mice with mutations or deletions any of these two 
genes lead to piebald lethal and lethal spotting mutants phenotypes 
respectively (Hosoda et al., 1994). Both mutant mice have white color, except 
for spotted regions in the head and rump. Mice is lacking enteric ganglia in the 
distal colon and die at juveniles from megacolon. The zebrafish null mutant for 
EDNRB has normal embryonic pigmentation but defective normal numbers of 
melanocytes and iridophores during metamorphosis and exhibit a disrupted 
pigment pattern (Krauss et al., 2014; Parichy et al., 2000). 
The best example to illustrate melanocytes migration is in the process of 
epidermis invasion. In mice, melanocytes migrate through dorsolateral 
pathway in the dermis, sequentially invade into the epidermis and then the into 
the hair follicle, where they colonize and differentiate. Melanoblast invasion of 
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the epidermis is coincident with epidermal stratification marked by different 
expression of the cell adhesion molecules E-cadherin and P-cadherin (Koster 
and Roop, 2007). For example, when melanocytes are invading, they express 
the same cadherins and subvide themselves based on their epidermis/dermis 
location. In epidermis, both keratinocytes and melanocytes expressed high 
level of E-cadherin; while dermal fibroblasts and melanocytes are low for both 
E-cadherin and P-cadherin; melanocytes in the hair matrix are E-cadherin low 
and P-cadherin high (Hirai et al., 1989). It is likely that the same process 
regulating epidermal stratification is also hijacked by melanocytes to invade. 
 
Melanocyte proliferation 
Epidermal black melanocytes are considered as a very quiescent population 
which normally rarely divide. To increase melanocyte number, developing 
animals usually increase proliferation of unpigmented melanoblasts or 
melanocytes stem cells, followed by differentiation into visible mature 
melanocytes.  
 
For example, in mice, melanoblasts undergo first waves of proliferation in the 
dermis before invading into epidermis, followed by a second waves of rapid 
proliferation in the epidermis (Jordan and Jackson, 2000; Mackenzie et al., 
1997; Nishikawa et al., 1991). At the hair follicle, melanocyte stem cells will 
then transiently proliferate and then differentiate into black melanocytes with 
each hair cycle and so add color to the hair (Nishimura et al., 2002, 2005). In 
zebrafish, most pigmented embryonic melanocytes are derived directly from 
neural crest/melanoblast differentiation, with a small population of black cells 
that maintain their proliferative capacity (Taylor et al., 2011). In adult zebrafish, 
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most melanocytes are derived from melanocyte stem cell differentiation 
(Hultman et al., 2009; Iyengar et al., 2015; Tryon and Johnson, 2012). In 
humans, a small percentage of melanoblasts have evidence of cell division 
during wound-healing related regeneration to restore the pool of black 
melanocytes. Once melanocytes are differentiated, it is generally thought that 
those cells lose proliferative potential.  
 
However, recently data also suggested there could a transient population 
where melanocytes are both differentiating and proliferative. Those cells (Kim 
et al., 2017) are not terminal differentiated yet therefore still maintain active 
proliferation potential. MITF activity is fine tuned in those populations as very 
high levels of MITF can halt cell division while absent or low MITF is anti-
differentiation (Carreira et al., 2006; Hoek and Goding, 2010). 
 
While black melanocytes in vivo rarely divide, tissue culture experiments 
suggest the evidence of actively dividing pigmented melanocytes and 
therefore help shed light on the mechanism regulating 
melanoblast/melanocyte proliferation. MAPK-kinase signaling, α-
MSH/cAMP/PKA, Endothelin/PKC signaling pathways all promote cell 
proliferation (Costin and Hearing, 2007), while TGF-β, INF-β, IL-1 and IL-6 
counteract these effect (Sulaimon and Kitchell, 2003). 
 
1.1.4 Environmental factors regulating melanocyte development 
Keratinocytes are the most well-known cell type regulating melanocyte 
development 
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Keratinocytes accounts for 90% of the cells found in epidermis (Müller et al., 
2014). It undergoes keratinization to form the dead superficial layer of the 
human skin. Once the superficial keratinized cells are dead, the actively 
dividing keratinocytes from the basal layers will move upward to replenish the 
pool. Keratinocytes are known potent regulators for melanocyte development 
through paracrine signaling, as they secrete growth factors such as endothelin 
1-3 (EDN1-3) (Hara et al., 1995; Saldana-Caboverde and Kos, 2010) and kit 
ligand (KITL) (Belleudi et al., 2010; Grichnik et al., 1998). These factors work 
on the corresponding receptors on melanocytes to regulate entire life-cycle of 
melanocytes as mentioned above, such as melanoblast specification, 
differentiation, proliferation and melanocytes migration. In response to UV, 
keratinocytes upregulate p53 expression which then subsequently induces 
POMC activity to secrete more a-MSH and ACTH (Cui et al., 2007). a-MSH 
and ACTH act upon the MC1R on melanocytes membrane to induce 
pigmentation during tanning. Besides p53, keratinocytes can secrete more 
interleukin-1 in an autocrine fashion to increase the production of ACTH, MSH, 
endothelin 1 and bFGF (Brenner and Hearing, 2008). During tanning, 
keratinocytes also exert protective effects on melanocytes by secreting NGF to 
prevent melanocyte apoptosis following UV exposure (Kadekaro et al., 2003).  
 
Interestingly, keratinocyte-derived factors share similar identity with those 
important in blood vessel formation (such as EDN, KITL and HGF). It is 
hypothesized that melanocyte migration is influenced by the same factor 
released from blood vessels which prime the dependence of melanocytes on 
the same factors post colonization. 
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Fibroblasts are a novel player regulating melanocytes development 
Fibroblasts are stromal cells that synthesize the extracellular matrix and 
collagen in dermis. Together with keratinocytes and melanocytes, they 
constitute the three major cell types in human skin. A few studies highlight the 
contribution of fibroblasts in the regulation of pigmentation (Duval et al., 2014). 
In the 1990s, scientists have discovered the roles of fibroblast produced-
extracellular matrix (ECM) in altering melanocyte morphology and significantly 
increasing melanogenic activity (Buffey et al., 1994). Recently, Dikkopf 1(DKK-
1) produced by fibroblasts in the palms and soles was shown to repress 
melanocyte growth and inhibit melanosome transfer, resulting in lighter color in 
patch of skin (Yamaguchi et al., 2008, 2009). Fibroblasts also have 
melanogenic effects by secreting bFGF, neuregulin-1 (NGR-1), SCF, 
hepatocyte growth factor (HGF) or keratinocyte growth factor (KGF) to 
promote melanocyte pigmentation (Imokawa, 2004) (Figure 6).  
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Figure 6. Hunan skin pigmentation is regulated by receptors, ligands and 
other factors. Keratinocytes and fibroblasts communicate with melanocytes 
through paracrine signaling. Figure adapted from (Yamaguchi et al. 2007). 
 
UVR is the most important extrinsic factor inducing tanning 
UVR induces melanocytes pigmentation mainly through the keratinocyte-
melanocyte paracrine signaling as mentioned above (Furuya et al., 2002). 
There are two types of skin tanning response, immediate tanning and delayed 
pigmentation. Immediate tanning appears 5 min to 10 min after UV exposure 
and can disappear days later. Immediate tanning is triggered by melanin 
redistribution from melanocytes to upper layer keratinocytes, and is largely 
due to UVA damage. Delayed pigmentation, in the other hands, takes days to 
weeks to occur. It is mainly caused by both UVA and UVB radiation, and 
results from transcriptional upregulation of genes in involved in melanin 
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synthesis (Costin and Hearing, 2007; Schiaffino, 2010; Tadokoro et al., 2005; 
Thody and Graham, 1998). UVR is also known to induce melanocyte 
dendricity, which serves as the channel to transfer melanosomes during photo 
protection (Jian et al., 2014). 
   
Sex hormones  
Although less is known about the molecular mechanism, the connection 
between hormone and pigmentation has been noticed for centuries. For 
example, pregnancy has long been linked with increases in skin pigmentation, 
commonly known as melasma.  
 
Natale et al have shown that physiologic concentrated estrogen (17b-estradiol) 
increases melanin synthesis while progesterone counteract this effect (Natale 
et al., 2016). Sex steroids modulate melanin synthesis pathway through a 
classical signal transduction similar to α-MSH, which activates adenylate 
cyclase increases cAMP and leads to phosphorylation of CREB. CREB then 
transcriptionally activates MITF. Using both primary human melanocyte culture 
and 3D skin models, they proposed that estrogen and progesterone stimulate 
G protein-coupled estrogen receptor (GPER) and progestin and adipoQ 
receptor 7 (PAQR7) on melanocyte membrane respectively (Hirobe, 2011; 
Natale et al., 2016). These findings suggested a rich and complex components 
of GPCRs other than MC1R on melanocyte membrane that could affect 
melanin production. They also noticed the presence of others GPCRs such as 
histamine and leukotriene receptors with unknown functions. 
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Using immunochemistry and RT-PCR, Tadokoro et al located the androgen 
receptor expression in the nuclei of cultured human genital melanocyte cells. 
Furthermore, they reported that androgen is another stimulator for 
pigmentation by increasing tyrosinase activity in human genital melanocytes 
cells (Tadokoro et al., 1997), revealing one mechanism to explain the 
enhanced pigmentation after puberty. 
 
Thyroid hormone 
Hyperpigmentation is one of the side-effect from hyperthyroidism which could 
be attributed to an elevated secretion of pituitary adrenocorticotropic hormone 
compensating for accelerated cortical degradation (Diven et al., 1989). In 
cattle, T4 addition has been shown to affect pigmentation and hair growth 
(Safer, 2011). Recently in zebrafish, thyroid hormone has been shown to 
influence pigmentation cell patterning by promote xanthophores differentiation 
(a fish specific pigment cell type) while attenuating melanophores (fish 
ortholog of melanocytes) proliferation and survival (Guillot et al., 2016; 
McMenamin et al., 2014).  
     
Fatty acids    
Fatty acid is recently shown to regulate tyrosinase ubiquitination and 
tyrosinase proteasomal degradation. Specifically, linoleic acid (an unsaturated 
fatty acid)  increases tyrosinase degradation whereas palmitic acid (a 
saturated fatty acid) counteracts this effect and increase tyrosinase activity in 
mouse melanoma cells (Ando et al., 2004). Therefore, many other saturated 
fatty acids such as palmitic acid, palmitoleic acid and stearic acid could induce 
B10 melanocytes differentiation (Hirobe, 2011).    
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1.2 Zebrafish as a model organism  
1.2.1 Background 
Scientists could not appreciate the beauty of basic molecular and cell biology 
without the aid of model organisms (Davis, 2004). Back in the eighteenth 
century, biologists approached many problems using observation, where they 
looked for evidence of divergence and convergence across species and came 
to a general solution to explain the mechanism. These efforts have led to 
many of early discoveries, such as linnaean classification, evolution by natural 
selection and embryology. By the end of the nineteenth century, more rigorous 
experimental biological approaches led to a standardized system to study 
general biological principles. These boosted the utilization of peas (which 
contributed to classical genetics), Arabidopsis (which serves as a multicellular 
form system to study plant biology) (Somerville and Koornneef, 2002), 
roundworm (Caenorhabditis elegans, with which scientists elegantly showed 
the course of development at the level of individual cell) (Ankeny, 2001; 
Brenner, 1974; White, 2013; White et al., 1986), fruit fly (Drosophila 
melanogaster, which gave rise to a groundbreaking of phenotypic and genetic 
information) (Nüsslein-Volhard and Wieschaus, 1980), E. coli, Salmonella and 
phages (which made molecular biology experiments approachable) and mice 
(which represent a mammalian system with relevance to human disease) 
(Paigen, 2003). All those model organisms have shared advantages with a 
relatively smaller size, easy to maintain in laboratory and most importantly, the 
availability of mutants. Through the study of numerous mutants, biologists 
mapped chromosomes, deciphered the genetic basis of each phenotype and 
put together signalling and transcriptional pathways.  
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In the late 1960s, G. Streisinger, a phage geneticist who had previously had 
tremendous success in understanding the genetic code and intracellular 
development of phage T4, decided to switch into developmental biology using 
something he was interested as a hobby: zebrafish (Danio rerio) (Grunwald 
and Eisen, 2002). Zebrafish began to thrive in the scientific community when 
researchers realized they need a vertebrate system to advance what they 
learned in C. elegans and Drosophila. This chapter will discuss the unique 
advantages with zebrafish as a genetic tool, then focus on the history of using 
zebrafish to study pigmentation, an obvious decision derived from the 
“zebra”-”fish” name. Finally, this chapter will touch on using zebrafish as a 
model to study human disease especially cancer.  
      
1.2.2 Advantages of the zebrafish system 
Cost effective 
Zebrafish is a cost effective model organism. Zebrafish has a relatively small 
size (3–4 cm long as an adult) (Figure 7), which make them very easy to 
maintain in large quantity in the laboratory environment. Zebrafish have a 
relatively short sex maturation time with 2-3 month old fish being able to 
breed, which makes genetic studies possible. Moreover, a pair of zebrafish 
adults are able to produce a few hundreds eggs in one morning, allowing for 
enough animals in a high throughput experiment. Once fertilized, zebrafish 
embryos are develop quickly with the majority of organs being formed by 48 
hours post fertilisation (hpf). More importantly, both embryos and adult 
(because of the engineered mutant casper), are transparent (White et al., 
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2008), which made direct observation down a dissecting microscope possible 
(Patton and Zon, 2001). 
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Figure 7.  Zebrafish share similar organs with human. Shown are larval at 
3dpf (Top) and adult (Bottom) zebrafish organs. Figure adapted from 
(Santoriello and Zon 2012). 
 
Chemical screens 
Zebrafish are highly suitable for chemical screens. As mentioned above, 
zebrafish can produce thousands of embryos per morning. Moreover, 
zebrafish embryos are small enough to be screened directly in multi-well 
plates. Compared to traditional screening using cell lines, zebrafish are better 
suited for drug discovery as they are living intact animals that possess a fully 
functional digestive and metabolism system (Tamplin et al., 2012). In addition, 
with abundant mutants available (Kettleborough et al., 2013), it is easy to 
combine zebrafish mutants with compounds to perform suppressor or 
enhancer screen. Screening for compound that can rescue a mutant 
phenotype into a wildtype (WT) is called a suppressor screen (Peterson et al., 
2000, 2004; Stern et al., 2005) (Figure 8). Screening for drugs that could bring 
out a new phenotype in a sensitized background is called an enhancer screen, 
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where the targets are thought to be essential in promoting a phenotype in 
combination with the sensitized genotype in the case of an agonist as a hit.   
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Figure 8. Chemical screen to look for compounds alternating a certain 
phenotype. Zebrafish embryos are tested in a 96-well place format. 
Compounds from an established library are added to each well to assay for 
their effects on a certain developmental phenotype. The hit compound that 
reaches desired phenotype would be retrieved from the library and 
reconfirmed. Figure adapted from (Tamplin et al. 2012). 
 
Rich tools are available for genome editing 
It is relatively straightforward to make transgenic zebrafish by microinjection of 
plasmids into a 1-cell stage embryo. Because of the large number of embryos, 
scientists can generate a large number founders to study gene expression in 
vivo. With the emergence of genome-editing tools, such as TALENs (Dahlem 
et al., 2012), zinc finger nuclease (Foley et al., 2009) and CRISPR-Cas9 (Irion 
et al., 2014), researchers now routinely perform gene knockout and gene 
knock-in reverse genetic experiments in zebrafish. Zebrafish can be also used 
in forward genetic screen using random N-ethyl-N-nitrosourea (ENU) 
mutagenesis (de Bruijn et al., 2009), which generates a large number of 
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mutant and enables identification of novel genes associated with a desired 
phenotype (Driever et al., 1996; Haffter et al., 1996). 
 
1.2.3 Zebrafish have a long history in pigmentation research 
The zebrafish has a beautiful layout of adult pigment cells with alternating 
black and white stripes, corresponding to a  “zebra-like” pattern. Like other 
vertebrates, zebrafish possess pigment cells that arise from two distinct 
embryonic sources: one derived from neural crest cells and located between 
the dermis and epidermis; and those that originate from the optic cup and 
comprise the retinal pigment epithelium (RPE) (Mort et al., 2015). Zebrafish 
have three classes of pigment cells: black melanophores, yellow 
xanthophores, and silvery iridophores. Dark stripes contain melanophores and 
iridophores, whereas light stripes include xanthophores and iridophores 
(Parichy, 2003).  
 
Zebrafish have a two waves of pigment cell formation to pattern the embryonic 
pigmentation and adult pigmentation, with both of them being derived from a 
SOX10+ neural crest cells. The embryonic pattern is formed by melanocytes 
that directly specified from SOX10+ neural crest into an SOX10+/MITF+ 
melanoblast. The adult melanoblasts originate from a melanocyte stem cell 
population that is set aside during embryo stage and re-activated during 
metamorphosis. Melanocyte stem cells reside at the dorsal root ganglia and is 
dependent on ERB and KIT pathway for specification and survival (Hultman et 
al., 2009). 
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Zebrafish have clearly defined pigment phenotypes and share conserved 
pathways regulating melanocytes biogenesis. Scientists recovered many 
pigment mutants from pet stores stock and from there started pigment genes 
research.  These are some of early zebrafish pigment mutants that paved the 
road for pigment research (Figure 9) (Kelsh et al., 1996; Streisinger et al., 
1986). 
 
Figure 9. Zebrafish mutants with pigment cell abnormalities. Figures 
adapted from Dr. David Parichy’s website. 
 
Albino 
Albino, a mutant in slc45a2 gene. Streisinger recovered the first described 
albino mutant albb4 (Streisinger et al., 1986). Albino fails to melanize by 2 days 
post fertilization and does not have pigmentation in neither RPE nor neural 
crest-derived melanophores. The human orthologous gene is involved in 
human skin color disease OCA4 (Newton et al., 2001). slc45a2 regulates 
melanosomal pH homeostasis, with defective proper pH homeostasis leads to 
tyrosinase enzymatic activity quenching (Dooley et al., 2013).  
      
Golden 
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Golden, a mutant in slc24a5 gene. Lamason et al characterized this mutant 
and showed that golden zebrafish has delayed and reduced development of 
melanin pigmentation. At approximately 48 hpf when there is evident melanin 
deposition in melanophores, golden are still pale. By 72 hpf and all the way 
into adult, golden melanophores and RPE begin to develop pigmentation that 
is lighter than that of wild type. slc24a5 is a melanosome-enriched calcium 
exchanger that is critical in regulating melanosome number and structure 
(Lamason et al., 2005). Importantly, this gene is responsible for a large 
amount of the variation in human skin color between Caucasian and African 
populations (Lamason et al., 2005).   
 
Sparse 
Sparse corresponds to a mutation in the c-kit gene. Parichy (Parichy et al., 
1999) et al showed that sparse embryos initially have normal melanized 
melanophores but by 11 days post fertilization (dpf) all the melanophores are 
dead. As the early melanophores fail to migrate, this suggests that c-kit is vital 
for melanophore migration and survival. As a consequence,  sparse adults 
have half the number of melanophores compared to WT animals.    
 
Rose 
Rose has mutation in the ednr1b gene. Parichy et al showed that rose mutants 
have normal embryonic pigment but fail to develop normal numbers of 
melanocytes and iridophores during metamorphosis and therefore exhibit a 
disrupted adult pigment pattern. EDNRB binds to all three endothelin ligand 
(EDN1-3) with equal affinity. Activated EDNRB1 protein leads to 
phosphorylation of protein kinase C (PKC), mitogen-activated protein kinase 
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(MAPK) and CREB, which turn on MITF mediated melanocyte differentiation 
(Parichy et al., 2000). 
     
Leopard 
Leopard is due to a mutation in the connexin41.8 gene. Watanabe et al 
showed that leopard mutants have spotted skin pattern instead of stripes. 
There are different leopard alleles, such as leot1, leotq270 and leotw28 with each 
showing different skin-pattern phenotypes. Those mutations have defective 
channel function of connexin41.8, causing loss of cell to cell interactions 
(Watanabe et al., 2006). 
 
Nacre 
Nacre corresponds to mutation in the mitfa gene. Nacre mutants lack 
melanophores from embryos to adults, but have an approximate 40% increase 
in the number of iridophores at 3dpf. MITFA is the master transcription factor 
that specify the melanophore lineages, and lack of MITFA therefore leads to 
absence of melanophore cell phate (Lister et al., 1999).  
        
1.2.4 Zebrafish is a unique system to model melanoma 
Melanoma is a malignant skin cancer originating in transformed melanocytes. 
50%–60% of melanoma have BRAFV600E mutations which leads to 
uncontrolled activation of BRAF/MEK/ERK signaling pathway (Ascierto et al., 
2012). Patton et al. took advantages of those clearly defined genetic disorders 
in melanoma and generated the first transgenic melanoma model, where the 
BRAFV600E oncogene is specifically expressed in melanocytes under MITFA 
promoter; the tumor suppressor P53 is inactivated in this model to release 
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melanocytes from oncogene-induced senescence. Fish with only BRAFV600E 
developed moles similar to human nevi, whereas the double mutants of 
BRAFV600E and p53-/- form melanoma starting at four months with 100% 
penetrance (Figure 10).These melanomas closely resemble human cancers at 
the morphological, mRNA expression and genomic alteration levels (Patton et 
al., 2005).  
 
 
Figure 10. A transgenic zebrafish melanoma model (mitfa:BRAFV600E; 
p53-/-), with the human oncogene BRAFV600E driven by a zebrafish 
melanophore specific promoter mitfa. Adult zebrafish form spontaneous 
tumors in a time window from 2 to 24 months, with 100% penetrance. Figure 
adapted from (White et al., 2011). 
 
White et al. used this transgenic model to identify a transcriptional signature of 
early melanomas. This revealed a significant overexpression of neural crest 
related genes, particularly the embryonic neural crest marker crestin as well as 
other genes such as BACE2. They then performed a chemical suppressor 
screen to identify compounds which suppressed this neural crest signature. 
They identified inhibitors of dihydroorotate dehydrogenase (DHODH) which 
could suppress crestin+ neural crest signature and inhibit melanoma growth 
for human cells (White et al., 2011). DHODH inhibitor leflunomide is currently 
being tested in phase I/II clinical trials and this translational finding suggested 
how scientists could take advantages of the abnormal dependence on 
embryonic gene programs to suppress melanoma growth. Moreover, these 
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observations led to additional work showing the importance of neural crest 
genes such as SOX10 as important for melanoma initiation (Kaufman et al., 
2016). 
 
Ceol et al. further modified the tumor model by breeding them into a mitfa null 
mutant nacre. In these animals, they could couple melanocyte rescue with 
oncogene overexpression and examine the consequence of oncogene 
expression specifically only in transformed melanocyte. They identified that 
setdb1 as histone methyltransferase as recurrently amplified in melanoma 
which accelerates melanoma (Ceol et al., 2011). 
          
Transplantation-based methods have a big impact in tumor biology, where 
tumors can be dissected off from a transgenic tumor-bearing animal or from 
patient-derived xenografts (PDXs), and then serially transplanted into recipient 
animals. Zebrafish proves themselves to be applicable for those techniques 
(White et al., 2013). White et al have established a stable, fluorescently-
labeled zebrafish melanoma cell line (ZMEL-color) with an easily manipulated 
genome. Transplantation of ZMEL-color cell into transparent zebrafish casper 
for both embryos and adults, allows for highly sensitive measurement of 
melanoma cell behavior at single cell resolution (Figure 11). The ZMEL-color 
line is completely unpigmented in vitro, but once transplanted into casper, 
100% of the locally engrafted skin tumors regain pigmentation within ~7-14 
days after transplant, which is a reflection of melanocytic differentiation. Using 
this assay, they can visualize the gradual differentiation over time and study 
the influence of differentiation on tumor morphology, primary tumor growth, 
and metastasis (Heilmann et al., 2015; Kim et al., 2017).  
 33 
 
 
Figure 11. Tumor transplantation in zebrafish. (A) Transplant a primary 
tumor dissected from a tumor-bearing fish into a transparent adult casper 
mutant (middle) gives the resolution to observe single cell metastasis in a live 
animal (bottom). (B) Color labelled donor cells are transplanted into zebrafish 
embryos. Recipients can be used to test chemical efficacy in a high-
throughput screen, and to study the interplay between host fish genetic 
mutations with cancer cells. Figure adapted from (White et al. 2013). 
 
1.3 BACE2 
1.3.1 Background 
Beta-site amyloid precursor protein cleaving enzyme 2 (BACE2) is a 
transmembrane aspartic protease that belongs to β-secretase family. BACE2 
is also previously referred to as MEMAPSIN 1 or ASP1. BACE2 cleaves 
substrates to exert biological functions (Figure 12). This chapter will talk about 
BACE2 gene location and transcripts expression, known substrates and 
functions, its relevance to homolog BACE1 and then focus on the potential 
roles of BACE2 in melanocytes as a lineage factor.   
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Figure 12. Diagram of ectodomain shedding. Membrane-bound sheddase 
cleaves its substrates and sheds them off from membrane. Figure adapted 
from art work of Armin Kübelbeck, distributed under a CC BY-SA 3.0 license 
(Wikimedia Commons). 
 
 
1.3.2 BACE2 gene location and transcripts expression 
The human BACE2 gene is located on chromosome 21 in the Down’s 
syndrome region at 21q22.3. This region is triplicated in the genome of Down’s 
syndrome patients and also contains the APP gene (Acquati et al., 2000; 
Bennett et al., 2000). Human BACE2 has 518 amino acids, with 20 amino 
acids long N-terminal signal peptide and a propeptide domain immediately 
following after. BACE2 has two highly conserved aspartic protease enzymatic 
sites with sequence D(T/S)G(T/S) that are required to endocleave substrates 
(Ahmed et al., 2010). BACE2 has three disulfide bonds and shares similar 
tertiary structures with BACE1 (Bennett et al., 2000), with the aspartic 
protease active site facing the lumen or the extracellular environment. BACE2 
has a transmembrane domain followed by a carboxyl-terminal 80 amino acids 
long cytosolic tail  (Bennett et al., 2000). These features suggested that 
BACE2 belongs to type one transmembrane protein with single pass 
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transmembrane domain and has its N-terminus targeted to the ER lumen 
during synthesis. Intracellularly, BACE2 is localized either to the plasma 
membrane, endoplasmic reticulum, trans-Golgi network, endosomes and 
lysosomes, with a broad pH range for enzymatic activity while most effective at 
pH=3.5 (Kim et al., 2002). 
 
BACE2 is highly expressed in pancreas, colon, placenta, kidney, prostate,  
trachea, stomach and pigment cells, but has low or undetectable level in adult 
whole brain and most brain sub regions (Bennett et al., 2000). 
 
1.3.3 BACE2 function 
BACE2 is known to cleave the following substrates. 
 
Self-cleavage of BACE2 
BACE2 contains a prodomain that requires cleavage during post translational 
modification to become an active enzyme. BACE2 undergoes self-processing 
to remove its prodomain (Hussain et al., 2001; Yan et al., 2001). 
 
APP 
BACE2 was initially speculated to be a β secretase APP cleaving enzyme and  
responsible for generating Aβ through a series of in vitro experiments, similar 
to its homologue BACE1 (Hussain et al., 2000). However, further in vivo study 
suggested BACE2 instead behave like an α secretase and cleave APP protein 
at residues A-Phe19 and A-Phe20 (which occurs within the Aβ sequence), 
however BACE1 could not cleave at the same site. α site cleavage lowers the 
levels of Aβ and mediates the degradation of Aβ but not production of the Aβ-
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fibrils (Abdul-Hay et al., 2012; Ahmed et al., 2010; Fluhrer et al., 2002; Yan et 
al., 2001). Moreover, BACE1 null mice nearly abolished Aβ peptides 
production while the intact copy of BACE2 was still present, suggesting there 
is limited function of BACE2 in Aβ production. Moreover, there is little 
expression of BACE2 mRNA in the mouse neurons which suggests a limited 
complementation to BACE1. These all together imply that BACE2 works like 
an α-secretase and is not responsible for producing Aβ peptides in 
Alzheimer’s disease. 
      
PMEL 
In melanocytes, PMEL forms the sheet-like matrix of amyloid fibrils to allow 
melanin deposition. PMEL forms the amyloid fibrils through a series of 
proteolytic cleavages inside the melanosome. PMEL amyloidogenesis occurs 
during stage I and II of melanosome maturation and controls the ellipsoidal 
shape and striated ultrastructure of melanosomes. Melanosome structure 
integrity is essential for melanocyte health likely by sequestering toxic ROS 
produced during melanin synthesis.        
 
PMEL proteolytic cleavage is a multistep process: the full length PMEL is first 
cleaved by proprotein convertase (PC) into a Mα fragment and a Mβ fragment, 
connected by disulfide bonds. Then Mβ fragment is cleaved by BACE2 to be 
divided into a N terminal fragment and a transmembrane C-terminal fragment 
(CTF). CTF is cleaved through intramembrane proteolysis γ-secretase 
complex. Mα is also processed by unknown proteases into smaller fragments 
to form fibrils in melanosome (Kawaguchi et al., 2015). BACE2 is one of the 
key proteases that facilitate PMEL maturation inside melanosome. Lack of 
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BACE2 leads to defective formation of PMEL derived amyloid fibrils, altered 
early-stage melanosome morphology and silvery coat color mice (Rochin et 
al., 2013; Shimshek et al., 2016).       
 
TMEM27 
BACE2 cleaves TMEM27 in pancreatic β cells. TMEM27 normally increases 
pancreatic β cells proliferation, cell mass and augments glucose-stimulated 
insulin secretion. TMEM27 content on plasma membrane is negatively 
regulated by BACE2 shedding. Absence of cleavage stabilizes TMEM27 level 
in pancreatic β cells and leads to an increased β-cell mass, increased insulin 
levels, and eventually to reduce blood glucose levels (Esterházy et al., 2011; 
Stützer et al., 2013).  
 
1.3.4 BACE2 shares distinct functions compared to BACE1 
BACE1 and BACE2 shares 64% similarity in amino acids. Unlike other 
aspartic proteases, BACE1 and BACE2 both belong to type one 
transmembrane protein with a single pass transmembrane domain and a short 
cytosolic tail, which imply the membrane-bound nature of their substrates 
(Bennett et al., 2000). However, BACE1 and BACE2 have non-overlapping 
characteristics. Firstly, they localize to different compartments inside cells. 
BACE2 is diffusely expressed throughout both the early and late Golgi 
compartments while BACE1 is limited to the late Golgi and TNF (Yan et al., 
2001). Secondly, they have distinct tissue enrichment. BACE1 is highly 
expressed in neuronal cells, while BACE2 is more enriched in peripheral 
secretory tissues, such as pancreas, prostate, stomach, thyroid and pigment 
cells (Bennett et al., 2000). The differences in intracellular location and 
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expression suggest that BACE21 and BACE2 have different substrates 
profiles and possess distinct physiological functions. BACE1 is important in 
nerve cell myelination, retinal integrity and neuromast development 
(Venugopal et al., 2008), while BACE2 plays roles in enteric neural crest 
migration, melanocyte development, choroidal vasculature and insulin 
secretion.  
 
1.3.5 BACE2 is a potential lineage factor in melanocyte 
Lineage factors are genes that are preferentially enriched in a certain lineage 
of cells, important in fate decision, differentiation and survival (Cao et al., 
2011; Cheung and Nguyen, 2015; Garraway et al., 2005). They can be the 
initial transcription factors that activate a network of downstream proteins to 
specify this lineage, such as SOX10 and MITF in melanocytes (Harris et al., 
2010; Levy et al., 2006). Lineage factors can also be genes that produce cell 
type specific features such as melanin synthesis genes in melanocytes. In 
addition, lineage factors can also be the survival genes that are critical to 
maintain cell survival to deal with a changing environment, such as KIT in 
melanocytes. Finally, lineage factors can also be genes that fine-tune cell’s 
response to growth factors and hormone, to add on a cell type specific 
response to a general circulating factor.  
 
BACE2 is highly expressed in melanocytes as well as melanoma, probably 
due to its enzymatic activity to cleave PMEL in melanocytes (Barretina et al., 
2012; Rochin et al., 2013). In mice, BACE2 null melanocytes displaying 
abnormally melanosome structure and “silvery” coat color further confirm this. 
In zebrafish, bace2-/- mutant display a striking melanocyte morphological 
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phenotype that is distinct from pmela-/- mutant (van Bebber et al., 2013; 
Walter, 2013), suggesting BACE2 could have alternative function in 
melanocytes and act as a lineage factor in regulating melanocyte morphology.  
 
1.4 insulin/PI3K/mTOR signaling  
1.4.1 Background 
PI3K/AKT/mTOR signalling are critical in a wide range of cellular process such 
as cell growth, survival and nutrients metabolism (Figure 13). The major 
players in the pathway: phosphatidylinositide 3-kinases (PI3Ks), AKT and the 
mechanistic target of rapamycin kinase (mTOR) are essential in development 
as loss any of the major genes results in embryonic death (Napolitano and 
Ballabio, 2016; Zarogoulidis et al., 2014). Moreover, the pathway is frequently 
activated or amplified in cancers and has been an important focus of cancer 
research (Engelman, 2009; Porta et al., 2014).  
 
Insulin is a circulating hormone that classically known to be released by 
pancreatic β cells into the bloodstream. Insulin regulates glucose and lipid 
homeostasis by binding to the insulin receptor tyrosine kinase (IR), which 
phosphorylates and recruits different substrate adaptors such as the insulin 
receptor substrates (IRS). Phosphorylated IRS then provides binding sites for 
numerous signaling partners, such as PI3K. PI3K then activates AKT which 
phosphorylates mTOR. mTOR has numerous downstream effectors, (which 
reflects the pleiotropic functions of mTOR), such as 4EBP1 and P70S6 kinase 
(S6K). They regulate translation initiation necessary for cell metabolism 
(Lizcano and Alessi, 2002).  
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This chapter will first discuss the specific structure and function of four major 
players in this signaling cascade: insulin, insulin receptor, PI3K and mTOR. 
Then this chapter will focus on the involvement of Insulin/PI3K/mTOR in 
embryonic development, with specific emphasis on cytoskeleton organization. 
Finally, this chapter will examine the regulation of insulin receptor level and 
activity. 
 
 
Figure 13. Overview of insulin signaling. Figure adapted from (Haeusler et 
al. 2018). 
 
1.4.2 Structure and function of insulin, insulin receptor, PI3K and mTOR 
Insulin          
Human insulin is a 51 amino acid peptide composed of  A and B chains. A 
chain and B chain are 21 and 30 amino acids long respectively, with A chain’s 
N- and C-terminal helices linked to the central helix of the B chain via two 
disulphide bonds (Weiss et al., 2000). 
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Insulin is known to be synthesized inside the β cells of the pancreatic islets as 
pre-proinsulin and then processed into proinsulin. Pre-proinsulin synthesis 
occurs in the rough endoplasmic reticulum, as a 100 amino acid long peptide 
consisting of a signal peptide, the B chain, the connecting (C) peptide and 
then the A chain. The signal peptide is removed in the endoplasmic reticulum 
to form proinsulin. Proinsulin is transferred by secretory vesicles from rough 
endoplasmic reticulum to Golgi (Fu et al., 2013). Proinsulin is further wrapped 
inside storage vesicle to leave Golgi, during which proinsulin is converted into 
mature insulin. Insulin is packed inside dense-core granules and is released 
from the islet into the portal veins in response mainly to glucose (Hou et al., 
2009). 
 
Elevation of blood glucose is a strong stimulus to release insulin in two 
phases: an initial rapid insulin secretion and a 2nd mild but sustained release 
(Wilcox, 2005). β cell glucokinase is the key sensor for glucose level. When 
glucose enters β cell, glucokinase phosphorylates glucose to glucose-6-
phosphate (G6P), generating ATP. ATP production results in closure of K+-
ATP dependent channels and leads to membrane depolarization. Voltage-
dependent calcium channels are open because of the depolarized membrane 
and lead to an increase in intracellular calcium concentration. Elevated 
calcium level eventually triggers pulsatile insulin secretion (Wilcox, 2005). 
Secreted insulin acts on muscle and adipocytes cells by inducing glycogen 
and lipid synthesis and reducing lipolysis and gluconeogenesis (MacDonald et 
al., 2005).     
 
Insulin receptor  
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The insulin receptor belongs to the receptor tyrosine kinase (RTKs) family that 
can be activated by various ligands: insulin, IGF-1 and IGF-II (Ward and 
Lawrence, 2009). INSR gene encodes insulin receptor with two isoforms IR-A 
and IR-B due to alternative RNA splicing of exon 11. Both isoforms undergo 
post-translational proteolytic cleavage and results in α and β subunit, which 
could assembled by disulfide-linked to form a 320 kDa transmembrane insulin 
receptor (Belfiore et al., 2009). Each monomer is made of eight domains 
(Smith et al., 2010), as shown in Figure 14.  
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Figure 14. Insulin receptor structure. Figure adapted from art work of 
Fletcher01, distributed under a CC BY-SA 3.0 license (Wikimedia Commons). 
 
Ligand binds to the α subunit which leads to insulin receptor conformational 
changes and ATP binding to the β subunit. ATP binding then triggers 
phosphorylation of the specific Tyr residues in the β subunit and confers 
tyrosine kinase activity (Wilcox, 2005). Phosphorylated β subunit further 
phosphorylates intracellular insulin receptor substrate (IRS) which can bind 
other signaling molecules (such as PI3K) to mediate downstream cellular 
actions of insulin (Haeusler et al., 2018). 
 
In mammals, the insulin receptor is produced as a precursor protein, which is 
then proteolytically cleaved by the furin protease into α and β subunit, which 
together form a functional insulin receptor. An unknown protease further 
cleaves of the β subunit into a C-terminal fragment (CTF) (Kasuga et al., 
2007), analogous to PMEL processing.  
 
PI3K          
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Phosphatidyl-inositol-3-kinases (PI3Ks) are a lipid kinase family that can 
phosphorylate the inositol ring 3′-OH group in inositol phospholipids. Activated 
RTKs or GPCR can recruit PI3K to the adaptor proteins (such as insulin 
receptor substrate) by directly binding to phosphotyrosine consensus residues 
through one of the two SH2 domains in the adaptor subunit. Activated PI3K 
converts the substrate phosphatidylinositol-4,4-bisphosphate (PI-4,5-P2) into 
phosphatidylinositol-3,4,5-triphosphate (PI3,4,5-P3). PI3,4,5-P3 acts as a 
second messenger and recruits a subset of signaling proteins (such as AKT) 
harboring PH domains to the membrane (Porta et al., 2014). 
 
There are three classes of PI3K due to their difference in structure and 
substrate specificities in mammalian cells. Among the Class I, there are further 
division of subclasses IA and IB due to various regulation modes (Figure 15). 
Class IA PI3Ks include PI3Kα, PI3Kβ and PI3Kδ. While each isoform has its 
own p110 catalytic subunit from α to δ respectively, they can associate with 
any of the five regulatory isoforms: p85α, p85β and p55γ, all called p85-type 
regulatory subunits (Thorpe et al., 2015).  
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Figure 15. Different isoforms in PI3K family. PI3K is divided into three 
classes based on different compositions and in vivo substrates, with class I 
further divides into Class IA and IB. Abbreviations: P: proline-rich domains. 
C2:  membrane-interacting domains. PX: Phox homology domain. p85-BD: 
p85-binding domain. RBD: RAS-binding domain. iSH2: inter-SH2 domain. BH: 
breakpoint cluster homology. Figure adapted from (Thorpe et al. 2015). 
 
Class IB PI3Kγ are heterodimers that contain a p110γ catalytic subunit and 
coupled with regulatory subunits such as p101 or p87. Class I PI3K has 
different expression profile, with p110α and p110β are ubiquitously expressed 
and p110δ and p110γ are limited to leukocytes (Shymanets et al., 2013; 
Thorpe et al., 2015).  
 
When PI3K is inactive, regulatory subunit inhibits p110 kinase activity; when 
receptor tyrosine kinase (RTK) or GPCR is activated, class I PI3Ks are 
recruited to the cell membrane and the inhibition effect from the regulatory 
subunit is relieved and p110 phosphorylates PtdIns(4,5)P2 to generate 
PtdIns(3,4,5)P3 (Engelman, 2009).  
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mTOR  
Mechanistic target of rapamycin kinase (mTOR) is an essential protein for life, 
conserved from yeast to human. mTOR is a serine/threonine protein kinase 
that regulates protein synthesis, nutrient sensing and autophagy. Deregulated 
mTOR signaling contributes to cancer progression, diabetes and aging 
(Laplante and Sabatini, 2009). There are two complexes in the mTOR family: 
mTORC1 and mTORC2. The mTORC1 complex is made up of mTOR, Raptor, 
mLST8, and PRAS40. It distinguishes itself by sensitivity to rapamycin. It 
activates S6K and inactivates 4EBP1 to promote translation initiation for cell 
metabolism. The mTORC2 complex is made of mTOR, Rictor, Sin1, and 
mLST8. It is known to activate AKT, insulin receptor and insulin-like growth 
factor 1 receptors, thereby promoting cell proliferation and survival (Porta et 
al., 2014).  
 
mTOR promotes protein synthesis through two main downstream effectors: 
p70S6 Kinase 1 (S6K1) and eIF4E Binding Protein (4EBP). mTORC1 directly 
phosphorylates S6K1 to activate several substrates that promote mRNA 
translation initiation, such as eIF4B, a positive stimulus of the 5’cap binding 
eIF4F complex, and ribosomal protein S6 (rpS6), a component of the 40S 
ribosomal subunit. Phosphorylated rpS6 activates translation of the TOP 
mRNAs, which are mRNAs that contain an oligopyrimidine tract at their 5′-
terminus (5’-TOP). TOP mRNAs are mRNAs that are involved in translational 
machinery, such as ribosomal proteins and translation factors. Therefore 
mTOR-S6K1-rpS6 cascade is highly involved in the regulation of cell size, 
metabolism, proliferation and glucose homeostasis. mTORC1 phosphorylates 
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4EBP and releases the translation inhibition effects from 4EBP (Laplante and 
Sabatini, 2012; Saxton and Sabatini, 2017).  
          
1.4.3 Involvement of Insulin/PI3K/mTOR in early development   
Mice with germline loss of PI3K/mTOR often leads to embryonic lethality, 
therefore other model organisms serve as alternatives to dissect the roles of 
PI3K/mTOR in early development. In yeast (S. cerevisiae), TOR1 and TOR2 
control cell size and sense nutrient availability, as rapamycin treatment or 
TOR1 and TOR2 depletion arrests yeast growth in the early G1 phase and 
induces an inhibition of translation initiation showing characteristic of starved 
cells entering stationary phase (G0) (Barbet et al., 1996; Di Como and Arndt, 
1996). In fly (D.melanogaster), TOR or S6K null animals are lethal in embryo 
accompanied by smaller cell sizes (Montagne et al., 1999; Oldham et al., 
2000; Zhang et al., 2000). In zebrafish (Danio rerio), TOR is expressed 
ubiquitously in the early embryo. Rapamycin treatment or TOR knockdown 
leads to mild developmental delay up to 72 hpf and an arrested digestive tract 
development at the primitive gut tube stage (Makky et al., 2007). In mice, a 
germline mutation in the intronic region of TOR (which resulted in abnormal 
mRNA splicing and maintained 20% of mTOR kinase activity) leads to 
defective cell proliferation in the telencephalon and fails in rotation movement 
around the body axis and mice is lethal at 12.5 days post coitum. TOR null 
mice die shortly after implantation due to defective cell division in embryonic 
as well as extraembryonic cells (Hentges et al., 1999, 2001).  
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1.4.4 Involvement of PI3K/mTOR in cytoskeleton organization 
In mammals, Rho family of GTPases is well known to affect cytoskeleton 
organization by regulating F-actin maturation (Tapon and Hall, 1997). 
PI3K/mTOR has recently been implicated to be involved in cytoskeleton 
organization by rearranging actin filament.  
     
TOR2 is initially thought to be the only class in the mTOR family that regulates 
actin cytoskeleton through Rho GTPases. Factors known to activate mTOR 
signaling could induce cells spreading into the substratum and assembling of 
F-actin fibres, while mLST8 and mAVO3 siRNA knockdown (which are 
components only in TORC2) inhibited this process in NIH 3T3 cells. TOR2 KD 
induced F-actin assembly inhibition can be rescued using an active form of 
Rac or Rho (Jacinto et al., 2004). Moreover, Jacinto et al proposed that 
TORC2 is important in the formation of GTP-bound Rac1 as pull-down assay 
showed that there is 20–30% decrease in GTP-bound Rac1 in TORC2 siRNA-
transfected cells. Rictor knockdown cells (a component of TORC2) display a 
flatter and a square-like cell morphology, due to a reduced amount of 
phosphorylation of Protein Kinase C (PKC) which is known to affect 
accumulation of thick actin fibers in the cytoplasm (Sarbassov et al., 2004).  
 
Dendrites are the primary interaction sites between neuronal cells and 
different neurons have distinct dendrites morphology and pattern. PI3K is 
known to promote neurite outgrowth and retraction in neuronal cell (Leemhuis 
et al., 2004). There is evidence that PI3K-AKT-mTOR cascade induces the 
growth and branching of dendrites in hippocampal neurons in vitro. Inhibition 
of PI3K or knockdown of mTOR or p70 ribosomal S6 kinase greatly reduce 
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dendritic complexity (Jaworski et al., 2005). The upstream small GFPase Ras 
is also involved as constitutively active mutants of Ras could rescue dendrites 
growth from mTOR inhibition (Jaworski et al., 2005; Kumar et al., 2005).  
 
TORC2 regulation of cytoskeleton has an impact on neuron morphology 
(Angliker and Rüegg, 2013). Ablation of rictor (the core component in TORC2) 
in brain decreases the mean total neuronal dendritic length by 15%. The soma 
size of RICTOR null neurons is only 70% of the control neurons and has less 
complex neurites. Thomanetz et al further extended this observation into a 
mechanistic study where they proposed that TORC2 is important for PKC 
isoforms activation and expression, since PKCs are known to play a role in 
spinocerebellar ataxia and in shaping the actin cytoskeleton. RICTOR null 
neuron leads to reduced level of PKC and a reduced activation of GAP-43 and 
MARCKS (Thomanetz et al., 2013).  
 
TORC1 is also proposed to control the protein expression of the GTPases 
RhoA, Cdc42, and Rac1; rapamycin could inhibit this effect. 4EBP1 and S6K1 
are the intermediate effectors as expression of constitutively 
hypophosphorylated 4EBP1 or downregulation of S6K1 suppress expression 
of the GTPases family. Rapamycin-resistant and constitutively active S6K1 
could also partially prevent rapamycin inhibition effect (Liu et al., 2010). 
 
1.4.5 Regulation of insulin receptor function 
Defective insulin receptor signaling is one of the cause for insulin resistance 
which leads to type II diabetes. The insulin receptor is the bridge connecting 
extracellular ligand and intracellular signal transduction, and proper regulation 
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of Insulin receptor activity therefore is vital for systematic glucose 
homeostasis. Mutations in the insulin receptor gene are rare and is not likely to 
contribute to the reductions in insulin receptor function observed 
physiologically (Gao et al., 2013). Physiologically, there are multi-level 
regulations of insulin receptor activity: (1) regulation of insulin receptor 
enzymatic activity, or (2) regulation of insulin receptor content on plasma 
membrane at the level of transcription or post-translational modification 
(Youngren, 2007).  
 
Much is known about the regulators involved in modulating insulin receptor 
tyrosine kinase activity. Multiple proteins are known to affect insulin receptor 
autophosphorylation, which is the first event occured post insulin binding. PC-
1, also known as ectonucleotide pyrophosphatase phosphodiesterase 1, can 
directly bind to insulin receptor to block autophosphorylation (Maddux and 
Goldfine, 2000). LAR and PTP-1B are skeletal muscle specific tyrosine 
phosphatases that contribute to insulin receptor dephosphorylation (Ahmad 
and Goldstein, 1995). Phosphorylation of insulin receptor substrate (IRS) is 
the 2nd step in ligand binding. IRS is reported to be serine phosphorylated to 
inhibit its ability to serve as a substrate of insulin receptor, via JNK (Aguirre et 
al., 2002). Post-translational modification can also affect insulin receptor’s 
enzymatic capacity. In pancreatic β cells, glucosamine increases O-
glycosylation of both the insulin receptor and IRS-1, which leads to reduced 
insulin receptor autophosphorylation (D’Alessandris et al., 2004). Interaction of 
Grb14 with the insulin receptor does not affect insulin receptor 
autophosphorylation but still results in reduced IRS-1 phosphorylation, 
suggesting that tyrosine kinase activity can be uncoupled from its own 
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autophosphorylation level (Béréziat et al., 2002; Hemming et al., 2001; Kasus-
Jacobi et al., 1998). Insulin receptor activity can also be regulated at the level 
of RNA alternative splicing. Insulin receptor has two isoforms IR-A and IR-B 
due to splicing of exon 11, with IR-A having an increased responsiveness to 
IGF-I and IGF- II (Yamaguchi et al., 1991). 
 
Regulation of the number of insulin receptors on plasma membrane is another 
way to regulate its function. Mice that are double heterozygous for the insulin 
receptor and IRS have reduced insulin sensitivity and glucose tolerance 
(Brüning et al., 1997). This underlies the importance of having adequate 
insulin receptors on the plasma membrane. 
     
Transcription regulation of the insulin receptor is less understood. FOXO1 is 
proposed to function as a transcription activator that mediates insulin receptor 
transcription by binding to its promoter directly (Puig and Tjian, 2005). 
Moreover, insulin itself is also well known to decrease the amount of insulin 
receptor by promoting insulin receptor internalization and degradation 
(Okabayashi et al., 1989).  
 
Recently, E3 ubiquitination is identified as a novel mechanism negatively 
regulating insulin receptor level. E3 ubiquitin ligase MARCH1 ubiquitinates 
insulin receptor to decrease cell surface insulin receptor level, inducing protein 
degradation. As a consequence, loss of MARCH1 enhances hepatic insulin 
sensitivity while overexpression of MARCH 1 impairs it in mice (Nagarajan et 
al., 2016).   
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CHAPTER 2: DISTANT INSULIN SIGNALING REGULATES VERTEBRATE 
PIGMENTATION THROUGH THE SHEDDASE BACE2  
2.1 Introduction 
Vertebrate pigmentation is an essential component of mate selection, 
camouflage and protection against UV damage(Price et al., 2008; Yamaguchi 
et al., 2007). Pigment cell patterning during development involves a precise 
spatiotemporal control of cell number, differentiation and localization. This 
patterning requires close coordination of both short-range and long-range 
extracellular factors with cell-intrinsic melanophore gene programs. 
  
The major pigment cell type in humans is the black melanocyte, which 
corresponds to the black melanophore found in teleosts such as zebrafish. 
Across vertebrates, a cell-intrinsic transcriptional hierarchy orchestrates 
specification and differentiation(Mort et al., 2015). Melanocytes are derived 
from the neural crest, a population of sox10+ pluripotent cells that eventually 
give rise to lineage-restricted mitf+ melanoblasts(Ernfors, 2010; Sommer, 
2011). mitf itself activates pigment genes such as dct, tyr and tyrp1 and the 
melanoblasts then differentiate into melanocytes/melanophores. These cells 
are characterized by black melanin production and formation of cell dendrites, 
which in mammals transfers melanin packets into surrounding 
keratinocytes(Goding, 2007; Lin and Fisher, 2007). 
  
Local environmental factors crosstalk with these intrinsic melanophore gene 
programs to instruct their development. One example of this interaction is 
short range communication between endothelins (EDN1, EDN3) produced by 
keratinocytes after UV exposure(Garcia et al., 2008; Hara et al., 1995; 
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Imokawa et al., 1992), which then act on nearby melanophores with 
endothelin-B receptor EDNRB on the membrane(Baynash et al., 1994; Parichy 
et al., 2000). Keratinocytes can also secrete other short range factors such as 
alpha-MSH which act on melanocortin receptors (MC1R) on the 
melanophores(Abdel-Malek et al., 1995; Chakraborty et al., 1991). These 
short-range factors act as strong positive regulators of melanophore 
proliferation and differentiation, and their effects are ultimately abrogated when 
the UV signal inducing their expression is reduced. Interactions between 
neighboring pigment cells also regulates their survival and 
localization(Hamada et al., 2014; Mahalwar et al., 2016). Adjacent 
xanthophores can exclude melanophores during stripe consolidation by 
extending specialized cell projections called airinemes which interact with 
microenvironmental macrophages(Eom and Parichy, 2017; Eom et al., 2015; 
Nakamasu et al., 2009). 
  
Longer range factors such as endocrine hormones, can also control pigment 
patterning. Growth hormone/insulin growth factor (IGF) can induce 
melanophore proliferation and differentiation(Edmondson et al., 1999; 
Tavakkol et al., 1992) and melanin concentrating hormone released from the 
pituitary modulates melanosome trafficking to facilitate camouflage(Logan et 
al., 2006; Richardson et al., 2008). Thyroid hormones are critical to promote 
xanthophore differentiation while attenuating melanophore proliferation and 
survival(McMenamin et al., 2014). Because these hormones can pass through 
the bloodstream, it remains unclear how these more “general” factors are 
regulated within the melanophore lineage in a spatiotemporal manner, and 
how the melanophore turns off this signal. Such negative regulation is 
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essential to proper patterning, as excess melanophores could dramatically 
alter the appearance of the animal and render them susceptible to neoplastic 
growth. One hypothesis for this negative regulation is that these extracellular 
factors depend on lineage-specific gene programs within the melanophore to 
regulate their activity. 
  
In this study, we utilized the zebrafish to study the role of distant factors in 
melanophore patterning. The zebrafish is an ideal system to address this 
question since it allows for facile genetic manipulation and chemical genetic 
strategies in a whole-organism context. Using this system, we characterized a 
mutant called wanderlust that has a disruption of normal melanophore 
patterning, with an excess number of hyperdendritic, hypermigratory 
melanophores. This mutant harbors an inactivating mutation in the sheddase 
Bace2, a melanophore-enriched gene that has been linked to abnormal 
migration but through an unknown mechanism(van Bebber et al., 2013). Here, 
we show that Bace2 acts to negatively regulate insulin/phosphatidylinositol 3-
kinase (PI3K) signaling within the melanophores. This occurs due to the ability 
of Bace2 to cleave and degrade the insulin receptor specifically on 
melanophores. When Bace2 is lost, this leads to unregulated melanophore 
proliferation and migration, suggesting a mechanism that connects distant 
hormonal signaling to melanophore-specific gene programs. 
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2.2 Result 
2.2.1 The zebrafish wanderlust mutant has hyperdendritic melanophores 
due to a loss of Bace2 
In order to identify processes involved in pigment patterning, we characterized 
a zebrafish mutant called wanderlust that has a nonsense mutation in the 
sheddase bace2(van Bebber et al., 2013) (allele: bace2hu3332). This leads to an 
early stop codon in exon 1 (Figure 16). During normal embryonic 
development, mitf+ melanophore precursors emerge from the neural crest 
from 16 to 24 hr post fertilization (hpf) and then migrate along the dorsolateral 
migration pathway, where they move first caudally and then ventrally along the 
somite boundaries(Kelsh et al., 2009). At the point of maximal migration, 
approximately 48 hpf, melanophores are highly dendritic, but by 72 hpf, after 
they have mostly ceased migration, the melanophores become compact and 
retract their dendrites(Cooper and Raible, 2009). In contrast, the wanderlust 
mutant has extensively hyperdendritic melanophores throughout development. 
These melanophores appear in atypical locations and abnormally migrate into 
the caudal tail fin (Figure 17A). The hyperdendritic phenotype is maintained 
throughout embryogenesis and into adulthood (Figure 17B). Consistent with 
this, during metamorphosis we find an increased number of ectopic 
melanophores in the inter-stripe region in the wanderlust mutant (Figure 17C-
D). Transient knockdown of Bace2 using morpholinos (MO) in wild type (WT) 
embryos recapitulates the wanderlust embryo phenotype (Figure 17E), as 
does pharmacologic inhibition of Bace2 with the compound PF-06663195 
(Figure 17F). Measurement of the tailfin melanophores shows that wanderlust 
melanophores occupy a larger cell area compared to WT embryos (Figure 
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17G). Collectively this demonstrates that it is the loss of Bace2 function that 
leads to the defect in melanophore localization and morphology. 
 
Figure 16. Bace2 protein diagram. 
Schematic representation of zebrafish WT and Bace2-/- protein as found in the 
wanderlust mutant. Zebrafish Bace2 is a type I integral membrane β secretase 
that contains two DTG and DSG protease sites within its extracellular/lumenal 
domain. The wanderlust mutant (Bace2-/-) has a C to A nonsense mutation 
leading to a truncated protein with size of 56 amino acids (aa), lacking both 
protease sites. TM=Transmembrane domain. 
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Figure 17. The zebrafish wanderlust mutant has hyperdendritic 
melanophores due to a loss of Bace2. 
(A) Brightfield imaging shows that the wanderlust melanophores are 
hyperdendritic compared to WT fish (arrowhead) in the tail fin at 72hpf. 
Labeling of the melanophore cell membranes (bottom panel) using the 
Tg(tyrp1b: membrane-mCherry) line demonstrates that this is due to a change 
in cell morphology rather than a redistribution of melanin. 
(B) These hyperdendritic melanophores are maintained into adulthood, and 
yield irregular stripe boundaries (arrowhead). 
(C-D) wanderlust mutants develop melanophores outside of the stripe during 
metamorphosis at 24 days post fertilization (dpf) (arrowhead). Inter-stripe 
melanophores number are quantified in (D); fish number: n(WT)=5, 
n(wanderlust)=5, two-tailed t test, **P<0.01. 
(E-F) Bace2 loss of function using morpholino knockdown (E) or 
pharmacological inhibition (F) phenocopies the wanderlust mutant. WT 
embryos are treated with Bace2 inhibitor (PF-06663195,100μM) from 48-
72hpf. 
(G) bace2-/- melanophores have larger cell area in the tail fin at 72hpf. 
Melanophore cell area is defined as the surface area covered by 
melanophores in the tailfin. Data are from five independent experiments, with 
total fish numbers: n(WT)=80, n(bace2-/-)=105, two-tailed t test, ****P<0.0001. 
All bar graphs are presented as mean ± s.e.m. Scale bars, 100μM (A, B 
middle and bottom panel, C, E, F), 0.5cm (B top panel). 
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2.2.2 Bace2 acts during melanophore differentiation 
We used a panel of neural crest and melanophore markers to determine when 
during development Bace2 is required using whole mount in situ hybridization 
(ISH). Whereas expression of the neural crest markers crestin and sox10 at 24 
hpf was normal in the wanderlust mutant (Figure 18A), by 72 hpf we noted an 
increase in pigmentation genes such as dct, pmela, tyr and tyrp1b in the 
mutant (Figure 18B), especially noticeable in the head region. This increase in 
pigmentation gene expression corresponds to an increase in visibly pigmented 
melanophores in the head region (Figure 18C-D). To determine whether these 
excess head melanophores were due to proliferation, we utilized a previously 
developed assay(Hultman and Johnson, 2010; Lee et al., 2010b; Lévesque et 
al., 2013; McMenamin et al., 2014) that uses existing melanin as a lineage 
tracer. In this assay, the animals are treated with the small molecule PTU, 
which prevents de novo melanin synthesis but does not affect existing 
melanin, so the appearance of new cells with melanin is indicative of division 
of a previously pigmented cell (Figure 19A-C). Using this assay, we find that 
PTU treatment did not prevent the increase in pigmented cell number, 
suggesting that Bace2 loss results in excess cell division of melanized cells 
(Figure 19D-E). To more precisely define the timing in which Bace2 acts, we 
treated WT embryos with Bace2 inhibitor PF-06663195 at various time 
windows from shield stage to 72hpf, and found that application from 48-72hpf 
is sufficient to give rise to the wanderlust phenotype (Figure 18E), coinciding 
with the period when the melanophores are actively pigmenting and 
differentiating. 
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Figure 18. Bace2 acts during melanophore differentiation. 
(A) At 24hpf, ISH shows the bace2-/- mutants have unaffected expression for 
neural crest markers and melanocytes markers. 
(B) But at 72hpf, ISH shows mRNA for the pigmentation genes dct, pmela, tyr 
and tyrp1b are elevated in bace2-/- mutants, especially in the head 
(arrowhead). 
(C-D) Consistently, bace2-/- mutants have increased numbers of pigmented 
melanophores in the head (arrowhead). Fish number n(WT)=55, n(bace2-
/-)=30, two-tailed t test, **P<0.01. 
(E) Treatment of WT embryos with 100μM Bace2 inhibitor (PF-0666195) from 
48-72 hpf is sufficient to phenocopy bace2-/-. Data are from two independent 
experiments, with total fish numbers: n(DMSO)=21, n(shield-24h)=45, 
n(shield-48h)=56, n(shield-72h)=72, n(24h-48h)=58, n(24h-72h)=40, n(48h-
72h)=49; One-way ANOVA followed by Holm-Sidak's multiple comparisons 
test, **P<0.01. All bar graphs are presented as mean ± s.e.m. Scale bars, 
200μM.  
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Figure 19. Bace2 deficiency leads to increased melanophore cell 
division. 
(A) Schema for testing the mechanism of increased melanophore cell number 
when Bace2 is loss. WT embryos were treated from 3-5dpF with 300μM PTU 
and/or 100μM Bace2 inhibitor (PF-06663195). PTU is a tyrosinase inhibitor 
that prevents new melanin synthesis to allow visualization only of previously 
pigmented melanophores. 
(B-C) Schema for two possible scenarios. If Bace2 loss of function induces 
pigment cell division as shown in (B), co-treatment with the Bace2 inhibitor 
and PTU would still increase melanophore cell number the same way as 
Bace2 inhibitor treatment alone. This is because PTU would not affect pre-
existing melanin and the newly derived daughter cells would inherit melanin 
from their mother cell. If Bace2 loss of function induces differentiation of 
unpigmented precursor cells as shown in (C),  co-treatment with the Bace2 
inhibitor and PTU would not increase visible melanophores cell number, as 
PTU would inhibit any new melanin from synthesis. 
(D-E) Co-treatment with the Bace2 inhibitor and PTU led to an increase in the 
number of pigmented melanophores, which necessarily must have come from 
previously pigmented cells division due to the effects of PTU, quantified in (E). 
The data are from three independent experiments, one-way ANOVA followed 
by Holm-Sidak's multiple comparisons test; fish number n(DMSO)=53, 
n(Bace2 inhibitor)=56, n(PTU)=54, n(Bace2 inhibitor+PTU)=61. **P<0.01, 
****P<0.0001. Epinephrine (5mg/ml) was used to aggregate melanin to 
facilitate cell counting. All bar graphs are presented as mean ± s.e.m. Scale 
bars, 200μM. 
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2.2.3 Bace2 acts cell-intrinsically within the melanophore lineage 
To test if Bace2 was acting cell-intrinsically within the melanophore lineage, 
we examined expression of bace2 by ISH and noted that it strongly overlaps 
with crestin, a pan neural crest marker that has been previously shown to 
mark all derivative lineages including melanophores (Figure 20A)(Kaufman et 
al., 2016; Luo et al., 2001; Rubinstein et al., 2000; White et al., 2011).  To 
more directly test whether Bace2 was acting cell-intrinsically, we created a 
stable rescue transgenic line in which the fugu dct promoter(Budi et al., 2011) 
drives WT Bace2. When crossed into the wanderlust mutant, we see a 
complete rescue of the melanophore defect in both the tail and head regions, 
consistent with a cell-intrinsic effect of Bace2 loss (Figure 20B-D). 
  
Taken together, these data indicate that Bace2 acts inside melanophore 
lineage and Bace2 deficiency leads to a hyperdendritic melanophore with 
increased proliferative and migratory capacity. 
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Figure 20. Bace2 acts cell-intrinsically within the melanophore lineage. 
(A) At 24hpf in WT embryos, double fluorescent ISH against the pan neural 
crest marker crestin (green) and bace2 (red) shows bace2 expression 
overlaps with crestin, suggesting bace2 is highly enriched in the neural crest 
lineage from which the melanophores are derived. 
(B-D) Melanophore-specific transgenic rescue of the bace2-/- mutant. A stable 
transgenic line was created in which the dct promoter drives Bace2 in the 
melanophores (along with a cryaa: YFP transgene marker). Founders were 
identified by expression of the YFP marker in the eye. Founders were crossed 
into other uninjected bace2-/- adult to generate F1 embryos. F1 embryos were 
scored for dendritic tail melanophore rescue at 3dpF (B, arrowhead) or for 
rescue of the head melanophores at 5dpF. F1 were divided into four groups: 
rescued, non-rescued, YFP positive and YFP negative. Chi-square with Yate’s 
correction was performed to associate rescue phenotype with YFP positive 
eye (quantified in C and D). ***P<0.001, ****P<0.0001.All bar graphs are 
presented as mean ± s.e.m. Scale bars, 10μM (A 120X), 30uM  (A 40X), 
100μM (A 10X, B left panel), 200μM (B right panel).  
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2.2.4 Pmela is a substrate for Bace2 but is not responsible for the 
wanderlust phenotype 
Bace2 is a transmembrane aspartic protease that acts as a sheddase, 
typically cleaving extracellular fragments to be released into the local 
microenvironment. Numerous BACE2 substrates have been previously 
described, including PMEL in melanocytes(Rochin et al., 2013; Shimshek et 
al., 2016) and TMEM27 in pancreatic β cells(Esterházy et al., 2011; Stützer et 
al., 2013). In mammals, the cleavage of PMEL by BACE2 is required for 
proper melanosome formation. Similarly, we found that in the zebrafish, Bace2 
is sufficient to cleave Pmela (Figure 21A) and loss of Bace2 leads to disrupted 
melanosomes as seen by electron microscopy (Figure 21B). However,  
genetic knockout of pmela (Figure 21C), or morpholino knockdown of 
pmela/pmelb(Burgoyne et al., 2015; Schonthaler et al., 2005) does not 
phenocopy the hyperdendritic/proliferative phenotype of the wanderlust mutant 
(Figure 21D-E). This suggests a Pmel-independent role for Bace2 in 
melanophore patterning and morphology. 
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Figure 21. Pmel is a substrate for Bace2 but is not responsible for the 
wanderlust phenotype. 
(A) zebrafish Bace2 cleaves Pmela. We constructed a fusion protein of 
zebrafish Pmela and a C-terminal Flag tag to detect cleavage by 
immunoblotting using Flag antibody. Expression of the fusion protein in HEK 
293T cells reveals an immature core-glycosylated P1 form of Pmela (~150 
kDa), the Mβ (~47 kDa), and the CTF (~18 kDa) when treated with γ secretase 
inhibitor DAPT (1μM), in a similar manner to human PMEL protein. Inhibition 
of human BACE2 using BACE inhibitor IV (1μM) increases the relative 
abundance of Mβ and decreases the abundance of the CTF, suggesting 
Bace2 cleaves Mβ and gives rise to CTF. Co-expression of the fusion protein 
and zebrafish Bace2 (zBACE2) leads to accumulation of cleavage product 
CTF, suggesting zebrafish Bace2 is sufficient to cleave zebrafish Pmela. 
(B) Electron microscopy of 72hpf embryos tail melanophores showed a 
difference in melanin distribution as well as melanosome (M) shape. 
Melanosomes in WT are round with a smooth outline and homogeneously 
filled with melanin (yellow arrow). bace2-/- melanophores have a darker hue in 
the cytosol (red arrow) and irregular melanosome membrane (yellow arrow), 
suggesting a leakage of melanin out of melanosomes into the cytosol. 
(C) Knockout of pmela using CRISPR-Cas9 in WT zebrafish leads to pale but 
not dendritic melanophores, similar to previously published fading vision 
mutant. This suggests that loss of pmela does not result in hyperdendritic 
melanophores. Melanophore membrane structure is visualized using 
Tg(tyrp1b: membrane-mCherry) strain at 3dpF. 
(D-E) Knockdown of pmelb alone (D) or co-knockdown of pmela and pmelb 
(E) using morpholinos in WT embryos does not lead to the hyperdendritic 
melanophore phenotype as seen in the bace2-/- mutant. Scale bars, 100 nM (B 
bottom panel), 1μM (B top panel), 100μM (C-E).  
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2.2.5 Bace2 regulates melanophore dendricity via PI3K/mTOR signaling 
Because sheddases can affect a wide variety of substrates, we therefore 
wished to functionally look for factors that could rescue the melanophore 
defects in wanderlust. To do this, we performed a chemical genetic screen to 
identify suppressors of the wanderlust phenotype (Figure 22A). We screened 
1,280 chemicals using the Sigma LOPAC library to identify compounds that 
could rescue the hyperdendritic mutant phenotype. For the screen, we 
quantified the area of tailfin melanophores at 72 hpf and identified chemicals 
which significantly reduced this in the mutant and scored these on a scale 
from 0 (no rescue) to 5 (complete rescue) (see Figure 23A for examples). 
Similar to our experience with prior chemical screens(White et al., 2011), we 
found that most chemicals had either no effect (~90.3%) or were broadly toxic 
(~8.9%) (Figure 22B). We identified four chemical hits that strongly rescued 
the mutant phenotype, all of which converge on PI3K/mechanistic target of 
rapamycin kinase (mTOR) signaling. Three PI3K inhibitors (AS605240, 
Wortmannin, LY-294,002) and one mTOR inhibitor (Temsirolimus) abrogated 
the hyperdendritic melanophore phenotype (Figure 22C-D). PP242, another 
mTOR inhibitor that is structurally distinct from Temsirolimus, phenocopied 
Temsirolimus. These compounds also rescued the structure of the 
hyperdendritic membrane structure, as seen using the tyrp1b:membrane-
mCherry transgenic line (Figure 23B and Movie 1-4). We determined if this 
rescue could be reversed by performing washout of the drugs at 72 hpf, but 
found that the rescue persisted up to 108 hpf (Figure 23C). To a much lesser 
extent, WT melanophore dendrites are responsive to inhibition of the pathway, 
especially during the time points when they are normally most dendritic (i.e. 48 
hpf) (Figure 24A-B). 
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We performed genetic knockdown experiments to determine the level at which 
this pathway caused the hyperdendritic phenotype. Among the small 
molecules we identified in our screen, the drug AS605240 was by far the most 
potent in rescuing the phenotype, which is a relatively selective inhibitor of the 
PI3K γ isoform. Consistent with this, we found that genetic knockdown of PI3K 
γ using a previously characterized morpholino(Li et al., 2015; Yoo et al., 2010), 
but not PI3K α, β or δ , rescued the melanophore dendricity (Figure 22E-F, 
Figure 32A). Morpholinos to mTOR itself resulted in near complete rescue of 
the phenotype (Figure 2E,G, Figure 32B-C). This is similar to what has been 
described for neuronal axon and dendrite patterning, in which PI3K signaling 
regulates downstream Rac/CDC42 signaling to drive dendrite neuronal 
morphology(Jiang et al., 2005; Markus et al., 2002; Shi et al., 2003). Our data 
suggest a specific role for PI3K/mTOR signaling in melanophore dendricity, 
which is exaggerated in the wanderlust mutant background. 
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Figure 22. Bace2 regulates melanophore dendricity via PI3K/mTOR 
signaling. 
(A) Scheme for chemical suppressor screen of the bace2-/- mutant. 24hpf 
bace2-/- embryos were treated with each compound from the Sigma LOPAC 
1280 library at 30μM for 48 hours, in order to identify chemicals which could 
rescue the melanophore defects. 
(B) Compounds were scored with a range of 0 (non-rescued, mutant-like) to 5 
(fully rescued, WT-like). 
(C) Top hits from the screen (with score of 4 and 5) converge on PI3K/mTOR 
signaling pathway. PI3K inhibitors AS605240 (110nM), Wortmannin (230nM), 
LY-294,002 (15μM), and mTOR inhibitors Temsirolimus (30μM), PP242 
(15μM) all fully rescue the bace2-/- hyperdendritic melanophores. 
(D) Quantification of tailfin melanophore cell area at 72hpf with hits from the 
screen (n=each fish, one-way ANOVA followed by Holm-Sidak's multiple 
comparisons test, ****P<0.0001). 
(E-G) Morpholinos knockdown of the PI3K γ isoform and mTOR in bace2-/- 
mutants rescue the phenotype analogous to what is seen with compounds 
from the screen, and the resulting tailfin melanophore cell area is quantified in 
(F) and (G). The data are from three independent experiments. Uninjected 
bace2-/- siblings (Control) are scored in the same manner, two-tailed t test, 
****P<0.0001. All bar graphs are presented as mean ± s.e.m. Scale bar, 
100μM. 
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Figure 23. PI3K/mTOR inhibition rescues dendritic melanophores in 
bace2-/-. 
(A) Representative pictures of melanophores with chemical screen scores 
from 0 (non-rescued, mutant like) to 5 (fully rescued, WT like). 
(B) Confocal pictures high magnification view of tailfin melanophores in 
response to PI3K inhibitor AS605240 (110nM), mTOR inhibitor PP242 (15μM) 
and insulin receptor inhibitor NVP-AEW541 (60μM). Tg(tyrp1b: membrane-
mCherry) fish were treated from 24hpf to 72hpf to visualize melanophore 
membrane structure. Also see Supplemental Movie 1-4. 
(C) PI3K/mTOR/Insulin receptor inhibitors effect on tail melanophore 
phenotype is not reversible by drug washout. wanderlust mutants were treated 
with inhibitors from 24hpf to 72hpf, then inhibitors were washed off extensively 
and embryos were imaged at 108hpf. Scale bars, 30μM (B), 100μM (A, C).  
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Figure 24. bace2-/- is hypersensitive to PI3K/mTOR inhibition compared 
to WT fish. 
PI3K/mTOR inhibition reduced WT melanophore dendricity at 48hpf (A, 
arrowhead), but the bace2-/- melanophores are more sensitive to this effect at 
both 48hpf and 72hpf (A and B, arrow). Treatment of WT and bace2-/- embryos 
with the PI3K inhibitor AS605240 (110nM) or mTOR inhibitor Temsirolimus 
(30μM) from 24-48hpf (A) or from 24-72hpf (B).  
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2.2.6 bace2-/- mutants have increased PI3K/mTOR activity 
To directly assess whether the hyperdendritic melanophores in the wanderlust 
mutant had abnormalities of downstream PI3K/mTOR signaling, we performed 
immunostaining for phospho-S6 ribosomal protein (p-S6) in the WT versus 
mutant fish. We quantified the p-S6 signal intensity in the melanophores from 
24-72 hpf by examining co-staining with fluorophore-labeled melanophores. 
This revealed a significant increase in p-S6 staining in the mutant from 48-72 
hpf (Figure 25A-C), and showed specific p-S6 staining pattern in the dendrites 
themselves at 72 hpf (Figure 25D). These data are indicative of increased 
output of the PI3K/mTOR pathway in the hyperdendritic melanophores of the 
wanderlust mutant. 
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Figure 25. bace2-/- mutants have increased PI3K/mTOR activity. 
Immunostaining against phospho-S6 ribosomal protein(p-S6), a downstream 
readout of PI3K/mTOR activity, shows elevated p-S6 signal that overlaps with 
fluorophore-labelled melanophores at 48hpf (B) and 72hpf (C). A 
representative pictures of 72hpf is shown in (D) and overlapping signals are 
marked by arrowhead. The data are from three (A), five (B) and five (C) 
independent experiments, two-tailed t test, ****P<0.0001, ns=not significant. 
All bar graphs are presented as mean ± s.e.m. Scale bar, 50μM. 
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2.2.7 The insulin receptor is a substrate for Bace2 and regulates 
melanophore dendricity 
The PI3K/mTOR pathway can be activated by numerous growth factor 
signaling pathways. We turned our attention to the insulin pathway, a 
canonical regulator of PI3K, because human BACE2 is known to regulate 
trafficking of the insulin receptor in pancreatic β cells(Casas et al., 2010) and 
can cleave the closely related family member IGF2R(Stützer et al., 2013). This 
led us to hypothesize that insulin receptor signaling drives the PI3K pathway in 
the hyperdendritic melanophores. To test this, we treated wanderlust mutants 
with the insulin receptor inhibitors BMS-754807 and NVP-AEW541, and found 
that both inhibitors were able to rescue the mutant phenotype (Figure 26A-B). 
Due to a teleost genome duplication, zebrafish have two insulin receptors 
(Insra and Insrb)(Toyoshima et al., 2008), so we used morpholinos to 
knockdown both of these receptors. Whereas each receptor itself was able to 
mildly rescue the mutant phenotype, the combined knockdown was much 
more effective (Figure 26C-D, Figure 32D). 
  
Insulin receptors are broadly expressed in multiple cell types(Garofalo and 
Rosen, 1988; Toyoshima et al., 2008; Uhlén et al., 2015), including 
melanophore lineage cells(Kim et al., 2017; Morvan et al., 2012). It is unclear 
how a general factor such as insulin can exert cell-type specific effects on cells 
such as melanophores. In mammals, the insulin receptor is produced as a 
precursor protein which is then proteolytically cleaved by the furin protease 
into α and β chains, which together form a functional insulin receptor(Bravo et 
al., 1994). Further cleavage of the β chain to a C-terminal fragment (CTF) has 
been variously ascribed to a lysosomal protease(Massague et al., 1981), a 
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thiol protease(Knutson, 1991) or ADAM proteases(Kasuga et al., 2007). Given 
that Bace2 is a transmembrane β protease, we hypothesized that Bace2 is a 
melanophore-enriched protease that can cleave the insulin receptor β chain to 
dampen insulin/PI3K signaling. To test this, we expressed a fusion protein of 
the zebrafish insulin receptor and a C terminal c-Myc tag (Insr-Myc) along with 
zebrafish Bace2 in HEK293 cells (which do not express any fish proteins).  
Expression of the Insr-Myc fusion protein alone revealed the full-length insulin 
receptor (~180 kDa) and the β chain (~90 kDa) product of furin cleavage 
(Figure 26E-F). This fusion protein is robustly cleaved by concomitant 
expression of Bace2, as shown by an accumulation of the CTF for both Insra 
(Figure 26E) and Insrb (Figure 26F). This effect was not seen with the 
catalytically-dead Bace2, and can also be abolished when cells are treated 
with Bace2 inhibitor PF-06663195. This demonstrates that Bace2 is sufficient 
to induce insulin receptor cleavage (Figure 27). 
  
Since Bace2 can induce β chain cleavage, this raised the possibility that loss 
of Bace2 in melanophores could serve to stabilize the β chain. To test this, we 
identified an insulin receptor antibody that recognized the endogenous 
zebrafish insulin receptor β chain (Figure 32D), and then measured its level 
after Bace2 inhibition in the ZMEL1 cells. After 24 hours, we found a 37% 
increase in β chain of the insulin receptor in the Bace2 inhibited cells (Figure 
26G-H), suggesting that Bace2 normally acts to limit insulin receptor levels on 
melanophores. 
  
To directly test whether insulin receptor signaling itself is responsible for the 
wanderlust phenotype, we created a transgenic construct in which the fugu 
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tyrp1(Zou et al., 2006) promoter drives a dominant negative insulin receptor 
substrate 2 (dnIRS2) to inhibit insulin signaling only in the melanophores. We 
then quantified tail melanophore dendricity as we did in the screen, and found 
a significant decrease in the transgenic animals compared with controls 
(Figure 26I-J). We also found that CRISPR knockout of insra/insrb in ZMEL1 
cells led to a significant decrease in the elongated/dendritic phenotype and 
cell number (Figure 28A-E). Taken together, these data are consistent with 
abnormal insulin receptor signaling induced by loss of bace2.  
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Figure 26. The insulin receptor is a substrate for Bace2 and regulates 
melanophore dendricity. 
(A-B) Inhibition of the insulin receptor in bace2-/- embryos using the insulin 
receptor inhibitors BMS-754807 (7.5μM) and NVP-AEW541 (60μM) rescue the 
hyperdendritic melanophores in the mutant, quantified in (B). bace2-/- embryos 
are treated from 24-72hpf, and the data are from three independent 
experiments. One-way ANOVA followed by Holm-Sidak's multiple 
comparisons test, *P<0.1, ****P<0.0001. 
(C-D) Morpholino knockdown of insulin receptor (Insr) in bace2-/- embryos 
rescues the hyperdendritic melanophores, quantified in (D). Insra and insrb 
morpholinos were co-injected into bace2-/- embryos to deplete all insulin 
receptors. The data are from three independent experiments, two-tailed t test, 
****P<0.0001. 
(E-F) Bace2 cleaves the insulin receptor. Expression of zebrafish Insra-Myc 
(E) and Insrb-Myc (F) fusion protein in HEK 293T cells give rise to full length 
insulin receptor and the β chain. Inhibition of γ secretase using DAPT (2μM, 
24 hours treatment) prevents the CTF from being cleaved, leading to CTF 
accumulation. Expression of zebrafish Bace2 (zBace2) on top of the Insra-Myc 
fusion protein leads to production of single CTF band (E). zBace2 addition 
leads to the production of two fragments from Insrb-Myc, one that migrates 
similarly to the CTF and additional larger fragment designated as CTF* (F). 
This is not seen with the enzymatic dead version of Bace2 (zBace2 dead) or 
after Bace2 inhibition with PF-06663195 (24 hours treatment). zBace2 dead 
was constructed by site-mutagenesis of two conserved catalytic sites aspartic 
acids into alanines (D98A and D292A). 
(G-H) Bace2 inhibition with PF-06663195 (25μM, 24 hours treatment) in 
ZMEL1 cells, which normally express both Bace2 and the insulin receptor, 
leads to accumulation of endogenous insulin receptor β chain, quantified in 
(H). The data are from five independent experiments, two-tailed t test, 
**P<0.01. 
(I-J) Melanophore-specific inhibition of insulin signaling in bace2-/- mutants 
rescues  melanophores hyperdendricity in the tail fin.  A mosaic F0 transgenic 
line was created in which the fugu tyrp1 promoter drives dominant negative 
insulin receptor substrate 2  (dnIRS2) fused to EGFP in the melanophores 
(along with a cmlc2: mCherry transgene marker). At 72hpf, tailfin melanophore 
cell area was quantified in uninjected control (Control) and transgene-positive 
injected embryos (J). The data are from three independent experiments, two-
tailed t test, ****P<0.0001.  All bar graphs are presented as mean ± s.e.m. 
Scale bar, 100μM.  
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Figure 27. Schematic representation of the protease cleavage steps of 
the insulin receptor.  
Insulin receptors are dimerized to form a functional unit as shown in the top 
panel. The full length monomer is first cleaved by furin, to yield the α and β 
chains. The β chain is then cleaved by Bace2 to yield the C-terminal fragment 
(CTF), which is then cleaved by γ secretase. When Bace2 is abundant, there 
is an accumulation of the CTF as cleavage product. When Bace2 is inhibited, 
there is an accumulation of the β chain. The ICD is not detectable in this 
experiment because it is unstable and quickly degraded by proteasome. 
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Figure 28. Insulin receptor regulates melanophore morphology and 
number in ZMEL1 cells. Two guide RNAs (gRNAs) targeting zebrafish insra 
and insrb respectively were co-nucleofected into ZMEL1 cells together with 
tracrRNA and recombinant Cas9 nuclease. A non-targeting gRNA was 
included as negative control. Surveyor nuclease assay was used to detect 
mutations in the insra (A) and insrb (B) genomic locus, resulting in two smaller 
digested PCR bands at the expected sizes (arrowhead). (C) Western Blot 
shows a pooled ZMEL1 knockout population leads to reduced Insr protein 
level. Membrane probed with antibody sc-711 recognizing insulin receptor β 
chain and β-actin as a loading control. Knockout of both insulin receptors in 
ZMEL1 cell using Crispr-Cas9 leads to less elongated/dendritic cell 
morphology (D) and reduced cell number (E), data are from three independent 
experiments. All bar graphs are presented as mean ± s.e.m. two-tailed t test, 
****P<0.0001. 
 
2.2.8 Insulin b is the upstream ligand that drives melanophore dendricity 
in wanderlust 
Finally, we wished to determine the source of the insulin ligand driving the 
wanderlust phenotype. Similar to the receptors, zebrafish have two insulin 
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ligands, Insa and Insb(Papasani et al., 2006), and we knocked these down 
using morpholinos. Knockdown of Insa had little to no effect, whereas 
knockdown of Insb had a significant rescue of the wanderlust phenotype 
(Figure 29A-B, Figure 32E). 
  
In humans, insulin is primarily produced in the pancreatic β-cells, whereas in 
teleosts and Drosophila, insulin peptides can be produced from other areas 
including the brain(Papasani et al., 2006). Whether humans produce insulin in 
the brain, or it is imported into the brain from the periphery, has been a source 
of some controversy although it is clear that insulin can have CNS-specific 
effects(Havrankova et al., 1979; Schwartz et al., 1992). To assess this in 
zebrafish, we performed whole-mount ISH for insa and insb ligand mRNA, and 
found that as predicted the insa transcript is exclusively produced in the 
pancreas (Figure 30A-B). In contrast, insb is initially expressed ubiquitously 
early in development but becomes gradually restricted to the head region and 
brain by 48-72 hpf (Figure 29C-E). To functionally exclude a role for pancreatic 
insulin in the wanderlust dendricity phenotype, we used morpholinos against 
pdx1(Kimmel et al., 2015) and hb9(Harrison et al., 1999; Kimmel et al., 2011) 
to completely ablate the pancreas. Whereas this maneuver led to a complete 
loss of Insa in the pancreas (Figure 30C), it had no effect on the wanderlust 
dendricity phenotype (Figure 30D). In addition, we find no consistent change in 
the size of the pancreas in the wanderlust mutants (Figure 30E). These data 
indicate that it is the Insb ligand, which is enriched in the head, that drives the 
melanophore dendricity, highlighting how a long-range factor can influence 
pigment patterning. 
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Taken together, these data demonstrate that the sheddase Bace2 modulates 
melanophore morphology in a cell-type specific manner by regulating insulin 
receptor cleavage and accumulation, which alters sensitivity to distant ligands 
such as insb (see Figure 31 for model). 
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Figure 29. Insulin b is the upstream ligand that drives melanophore 
dendricity in wanderlust. 
(A-B) Morpholino knockdown of the ligand insulin B (insb) in bace2-/- embryos 
rescues the hyperdendritic melanophores, quantified in (B). The data are from 
three independent experiments, two-tailed t test, ****P<0.0001. 
(C-E) Fluorescent ISH shows zebrafish insb ligand mRNA is initially expressed 
ubiquitously at 24hpf and then restricted to the head/brain region (arrowhead) 
in bace2-/- embryos at 48-72hpf, sense probe controls for background signal. 
All bar graphs are presented as mean ± s.e.m. Scale bar, 100μM (A), 150μM 
(C, D), 200 μM (E).  
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Figure 30.  Pancreatic insa ablation does not rescue the bace2-/- 
phenotype. 
(A-B) ISH shows insa mRNA is specifically expressed in pancreas at 24hpf (A) 
and at 72hpf (B) for both WT and bace2-/- embryos (arrowhead). 
(C) Immunostaining shows knockdown of either insa or pdx1/hb9 in bace2-/- 
mutants completely ablates insulin staining in the pancreas, while insb 
knockdown does not change pancreatic insulin level at 72hpf. Whole embryos 
were stained with anti-insulin antibody. 
(D) Co-knockdown of pdx1 and hb9 in bace2-/- mutants fails to rescue dendritic 
melanophores at 72hpf. 
(E) wanderlust mutant have slightly increased insa positive cell area compared 
to WT embryos at 72hpf, but Bace2 inhibitor and Bace2 morphant do not show 
significant differences to the control group, suggesting Bace2 loss of function 
does not consistently alter pancreatic β cell mass at 72hpf. n=each fish, two-
tailed t test, *P<0.05. All bar graphs are presented as mean ± s.e.m. Scale 
bars, 50μM (C), 100μM (A, B, D). 
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Figure 31. Graphical Abstract. 
Bace2 normally cleaves the insulin receptor (IR) to decouple the α chain (blue 
bar) from the tyrosine kinase domain in the β chain (yellow bar) on 
melanophore cell membrane. wanderlust mutants are deficient in Bace2 and 
fail to cleave the insulin receptor, which leads to an accumulation of the β 
chain. Defective insulin receptor cleavage results in increased PI3K/mTOR 
signaling and sensitizing the melanophores to the effects of insulin B. 
PI3K/mTOR inhibition is sufficient to rescue wanderlust into resembling the 
wild-type melanophores. 
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Figure 32. Control experiments for morpholino knockdown. 
(A) Knockdown of PI3K α, β or δ isoforms using morpholinos does not rescue 
bace2-/- dendritic melanophores to the same extent as PI3K γ morpholinos, as 
shown in Figure 22E. 
(B) Knockdown of mTOR using mTOR splicing morpholino leads to depletion 
of mTOR protein in Western blot. Membrane probed with anti-mTOR antibody 
and β-actin as a loading control. 
(C) RT-PCR shows knockdown of mTOR using mTOR splicing morpholino 
leads to abnormal mRNA splicing. mtor fragment is amplified using primers 
adjacent to morpholino target sites. actin: input control. 
(D) Western blot shows co-knockdown of insra and insrb using morpholinos 
leads to decrease insulin receptor protein. Membrane probed with antibody sc-
711 recognizing insulin receptor β chain and β-actin as a loading control. 
(E) Knockdown of insa (Left) and insb (Right) using splicing morpholinos lead 
to abnormal mRNA splicing and expression in RT-PCR. Fragments are 
amplified using primers adjacent to morpholino target sites. actin: input control. 
Scale bars, 100μM. 
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2.3 Discussion 
It is increasingly recognized that vertebrate coloration is due to continuous 
interactions between pigment producing cells and their neighboring 
cells(Nakamasu et al., 2009);(Eom et al., 2015; Walderich et al., 2016). 
Although this has long been considered to consist primarily of short-range 
interactions (i.e. melanophore-iridophore, etc)(Frohnhöfer et al., 2013; 
Patterson and Parichy, 2013), recent data have highlighted a role for thyroid 
hormone in pigment patterning(McMenamin et al., 2014), and Aqp3a as a pore 
that can communicate with the external environment(Eskova et al., 2017). 
What has remained unclear is the manner in which long-range environmental 
factors interact with lineage-specific gene programs to regulate pigment 
pattern formation. Our data would suggest that a distant hormonal signal, 
insulin, can play a major role in this patterning by interacting with a 
melanophore-enriched gene, bace2. 
  
A major question our study addresses is how circulating hormonal factors like 
insulin can ultimately yield cell-type specific phenotypes. One explanation for 
such specificity is that each cell type has a set of lineage-restricted genes that 
regulates the level and activity of the insulin receptor. In the present study, we 
identify Bace2 as one such candidate lineage factor in melanophores. Our 
data indicate a model in which the endogenous role of Bace2 in melanophores 
is to dampen insulin/PI3K signaling, and loss of Bace2 activity leads to 
hyperactivation of the pathway. This would be consistent with the phenotypes 
we observe, including hyperdendritic, proliferative and migratory 
melanophores. PI3K/mTOR signaling is well known to regulate dendrite 
formation in other cell types such as neurons(Jiang et al., 2005; Markus et al., 
 92 
2002; Shi et al., 2003). Inactivation of PTEN, a negative regulator of PI3K, 
leads to highly migratory and metastatic melanoma cells(Dankort et al., 2009). 
  
Sheddases such as Bace2 are membrane-bound proteases that cleave the 
extracellular domain of transmembrane proteins and shed the soluble 
ectodomain extracellularly. They can act as both positive or negative 
regulators of downstream signaling. Sheddases such as ADAM17 (also known 
as TACE) cleave and activate epidermal growth factor (EGF) ligands, and loss 
of ADAM phenocopies EGF ligand mutants(Luetteke et al., 1993; Peschon et 
al., 1998). Similarly, cleavage of the Notch receptor by ADAM10 and ADAM17 
is required for release of the notch intracellular domain (NICD), where it can 
then move to the nucleus to influence downstream gene transcription(Brou et 
al., 2000; van Tetering et al., 2009). In contrast, sheddases can also act as 
negative regulators of receptor activity by quenching free ligands using the 
ectodomain from cleaved receptors. For example, the soluble form of the Mer 
proto-oncogene tyrosine kinase (MerTK) can bind to its ligand to limit Akt 
signaling downstream of endogenous MerTK(Cai et al., 2016; Sather et al., 
2007). A more straightforward way to dampen down receptor activity is to 
physically cleave the receptor proteins. ADAM10 inhibition leads to hepatocyte 
growth factor receptor (HGF-R/MET) accumulation and subsequent activation 
by its ligand HGF in liver metastasis(Kopitz et al., 2007; Miller et al., 2013; 
Schelter et al., 2011). Similarly, ADAM10 and ADAM17 can proteolytically 
cleave receptor tyrosine kinases such as AXL, and loss of ADAM cleavage 
leads to AXL accumulation on cell membrane and results in increase in 
mitogenic signaling activity(Miller et al., 2016; Orme et al., 2016). Our data 
suggest that Bace2 primarily acts as a negative regulator of insulin signaling 
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by proteolytically cleaving the insulin receptor. Interestingly, it has been shown 
that downregulation of RTK cleavage can be hijacked by tumor cells to acquire 
drug resistance, suggesting that sheddases are also under dynamic feedback 
regulation(Miller et al., 2016). 
  
In mammals, BACE2 has been shown to be enriched in pancreatic beta cells, 
where it cleaves TMEM27 and leads to increased secretion of 
insulin(Esterházy et al., 2011). BACE2 is also known to be expressed in 
mammalian melanocytes, where it serves to cleave PMEL to achieve 
melanosome maturation(Rochin et al., 2013; Shimshek et al., 2016). In 
contrast, our studies highlight a Pmel independent role for Bace2 in 
pigmentation, since we find that loss of function of pmela/b does not resemble 
the zebrafish wanderlust mutant. Instead, our data show that it is another 
substrate, the insulin receptor, which mediates the pigment phenotype. This 
highlights the functional plasticity of sheddases, which can have numerous 
different substrates to regulate cell-type specific effects. Whether Bace2 is 
important for zebrafish pancreas development remains to be determined, but 
pancreatic insulin is unlikely to play a role in pigment patterning since ablation 
of the pancreas with pdx1/hb9 morpholinos failed to rescue the wanderlust 
phenotype. Moreover, we did not see a strong signal of bace2 in pancreas 
during zebrafish embryogenesis by ISH, although this will need further study in 
the future. Insb is dynamically expressed. At 24 hpf it is expressed fairly 
ubiquitously, but then becomes gradually restricted to the head region by 48 to 
72 hpf. We did not see a strong enrichment of insb in the pancreas as noted 
before(Papasani et al., 2006). Based on this, we also tried the same insb 
probe from(Papasani et al., 2006) but were not able to consistently see a 
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greater signal in the antisense versus sense probe in the pancreas. Although 
we do not understand the nature of this discrepancy, we decided to primarily 
focus on the probe published by(Junker et al., 2014) for our studies since it 
correlated closely with their RNA-sequencing topography analysis and 
consistently gave us an excellent antisense:sense signal. 
  
It is likely that insulin cooperates with other long-range endocrine-related 
factors such as thyroid hormone(McMenamin et al., 2014). Although not 
specifically addressed in our study, one interesting consideration is how 
hyperinsulinemia leads to hyperpigmentation in humans, a well described 
phenomenon that typically occurs as part of the disease acanthosis 
nigricans(Hermanns-Lê et al., 2004). This is a condition specifically linked to 
other endocrinopathies such as diabetes mellitus, hypothyroidism, and 
polycystic ovarian syndrome, and thus the melanocyte responsiveness to 
insulin may be part of this pathophysiology. 
  
BACE inhibitors are being evaluated in clinical trials, primarily for the 
prevention or treatment of Alzheimer’s disease. This is due to the fact that 
BACE1 can cleave amyloid precursor protein, thought to be a major target in 
that disease. In contrast, BACE2 inhibitor may have utility for the treatment of 
diabetes, due to its capacity for increasing insulin secretion(Esterházy et al., 
2011). Many of the molecules developed so far have some but not complete 
selectivity for either isoform. Our data would suggest that inhibition of BACE2, 
in the context of hyperinsulinemia, may have effects on pigmentation via the 
PI3K pathway, and may increase the migratory capacity of these 
hyperdendritic melanocytes. Whether this has clinical consequences, 
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especially in regard to melanoma development, remains to be determined, but 
is an important area for future exploration. 
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CHAPTER 3: BACE2 AS A POTENTIAL TUMOR SUPPRESSOR IN 
MELANOMA 
3.1 Introduction 
3.1.1 Melanoma is a heterogeneous tumor type   
Melanoma, the deadliest form of skin cancer, is derived from pigment cells 
called melanocytes that arise from the neural crest (Uong and Zon, 2010). If 
diagnosed early, melanoma can often be cured by surgical resection. 
However, once it metastasizes, melanoma becomes extremely deadly (Gray-
Schopfer et al., 2007). Melanoma cells are heterogeneous populations with a 
wide degree of morphology, differentiation status and transcriptomics, but this 
heterogeneity is not taken into account when deciding upon treatment (Albino 
et al., 1981; Egger et al., 2013; Houghton et al., 1982, 1987). Many factors 
that could contribute to this phenotypic heterogeneity, and we wish to test the 
hypothesis that melanoma heterogeneity reflects diversity in melanoma 
differentiation states. 
  
3.1.2 The role of cellular differentiation in melanoma 
Genetic profiling and immunohistochemistry of patients samples and cell lines 
suggest there are three distinct melanoma differentiation states: 1) an 
undifferentiated, invasive state similar to a neural crest progenitor, 2) a 
partially differentiated/proliferative state, and 3) a terminally differentiated/non-
proliferative state (Chien et al., 2009; Eichhoff et al., 2010; Pinner et al., 2009; 
Tap et al., 2010). This model is sometimes called the “rheostat” model of 
melanoma in which cells both within and between patients can lie along a 
spectrum of differentiated states (Goding, 2011). Further, several in vivo 
studies show that melanoma cells can undergo phenotypic switching to 
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change their differentiation status (Eichhoff et al., 2010; Quintana et al., 2008, 
2010). Phenotypic plasticity enables melanoma cells to adapt to the various 
challenges that arise during tumor progression.  Initially, cells with greater 
proliferative abilities drive the expansion of the primary tumor. Subsequently, 
these cells can undergo dedifferentiation and a subpopulation of 
undifferentiated cells arises. Dedifferentiated cells have metastatic advantages 
that enable them to disseminate to distant organs (Hoek et al., 2008). Once 
there, success at nascent metastases depends on the cell’s ability to partially 
differentiate in order to regain their former proliferative capacity and colonize. 
Indeed this mechanism explains the initially paradoxical observation that 
melanoma cells that are partially differentiated are also the most proliferative 
(Hoek and Goding, 2010; Hoek et al., 2008; Vandamme and Berx, 2014). 
 
Both cell-intrinsic and microenvironmental factors have been hypothesized to 
control phenotype switching in melanoma, and emerging data has begun to 
identify some of these factors (Carreira et al., 2006). One central factor in 
phenotype switching is the transcription factor MITF (Hsiao and Fisher, 2014). 
MITF is a master regulator of melanocyte differentiation, and has been shown 
to be a lineage-specific oncogene amplified in malignant melanoma (Garraway 
et al., 2005; Goding, 2011). However, MITF has been shown to have a 
complex role in melanoma progression because it not only drives melanocytes 
into differentiation but also is essential in maintaining melanocyte survival 
(Garraway and Sellers, 2006; Hsiao and Fisher, 2014; Sáez-Ayala et al., 
2013). Another important factor is SOX10, a neural crest progenitor gene 
essential for both melanoma initiation and progression that directly 
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upregulates MITF expression (Kaufman et al., 2016; Mohamed et al., 2013; 
Shakhova et al., 2012). 
 
The clinical relevance of melanoma differentiation is an active area of 
investigation.  “Differentiation therapy” by inducing terminal differentiation and 
cell cycle exit was previously attempted to treat melanoma but was not 
successful (Abdi et al., 1988; Friedman, 2008; Houghton et al., 1987; 
McArthur, 2014; Ravandi et al., 1999), possibly because undifferentiated cells 
were forced into a partially differentiated, more proliferative phenotype 
(Carreira et al., 2006).  Further, differentiation signatures have an impact on 
drug sensitivity (Sáez-Ayala et al., 2013; Tap et al., 2010).  BRAF-mutant 
melanomas with the undifferentiated, neural crest gene expression signature 
have the highest level of resistance to vemurafenib, a BRAF inhibitor, while 
melanomas with the terminally differentiated gene signatures are least 
resistant (Konieczkowski et al., 2014). Accordingly, these signatures are 
correlated with different levels of MITF, which modulates the intrinsic 
sensitivity of melanomas to MAPK pathway inhibitors. Taken together these 
data imply that differentiation state has a profound effect on the 
heterogeneous melanoma phenotype.  
 
3.1.3 Bace2 in melanoma 
Chapter 2 suggested that in normal physiology, Bace2 is part of a program 
that pushes melanophores into a terminally differentiated states where they no 
longer cycling. When Bace2 is absent, melanophores are locked in an actively 
differentiating/proliferative state, leading to aberrant melanophore migration, 
proliferation and deposition of melanin in the wrong places. This is because 
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Bace2 modulates the strength of PI3K/mTOR inside melanophores, by 
cleaving and inactivating insulin receptors on melanophore membrane. When 
Bace2 is present, the insulin receptor is cleaved into half and the signal is 
turned off; when Bace2 is absent,the insulin receptor is intact, and the signal is 
on. 
 
Melanocytes are the precursor cells for malignant melanoma, and melanoma 
is known to inherit embryonic memory and addicted to lineage program (White 
et al., 2011). We would like to test if Bace2 as a lineage factor has an impact 
on melanoma proliferation and differentiation, and if these changes in 
differentiation status have a consequence on tumor progression.  
 
3.2 Result 
3.2.1 Bace2 expression in melanoma 
In order to study the roles of Bace2 in melanoma, we first examined Bace2 
expression and genomic alterations in melanoma. We crossed examine the 
Broad Institute Cancer Cell Line Encyclopedia (CCLE) and cBioPortal to check 
Bace2 expression and found that Bace2 is highly expressed in melanoma cell 
lines and melanoma tissues (Figure 33A-B) (Barretina et al., 2012; Gao et al., 
2013). We do not see consistent changes in genomic deletion, amplification, 
copy number or hotspots mutation, compared to other known lineage factors 
(MITF, SOX10) or tumor suppressor (CDKN2A) in melanoma (Figure 33C-E). 
As Bace2 has dual roles in melanocytes (cleaving PMEL for melanosome 
maturation versus cleaving insulin receptor to regulate cells proliferation and 
differentiation), it is likely that the enrichment of Bace2 simply reflects its role 
in PMEL cleavage in pigment cells and therefore it is hard to predict the 
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carcinogenic function of Bace2 based on expression level alone (Rochin et al., 
2013).  
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Figure 33. BACE2 is highly enriched in human melanoma cells, with little 
genomic alterations. 
(A-B) BACE2 mRNA is highly enriched in melanoma cell lines (marked by 
arrowhead) and in melanoma cell lines and patients samples (marked by 
arrowhead). Data is from CCLE (A) and cBioPortal (B).  
(C) While other melanocyte-enriched lineage factors MITF and SOX10 are 
significantly amplified and canonical melanoma suppressor gene CDKN2A is 
significantly deleted in melanoma, BACE2 locus is altered at 2.2% across a 
panel of melanoma cells and samples, without enrichment of amplification or 
deletions. Data is from cBioPortal. 
(D) BACE2 (previously named ASP) locus does not have hotspot mutations. 
Data is from cBioPortal. 
(E) BACE2 locus does not have copy number changes in melanoma cell lines. 
Data is from CCLE.  
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3.2.2 Loss of Bace2 increases zebrafish melanoma proliferation and 
differentiation, resulting in a highly invasive cells 
We utilized the ZMEL1 cell line, which is a zebrafish-specific melanoma cell 
line expressing high levels of bace2 along with other key pigment genes such 
as mitfa, dct, and tyr (Heilmann et al., 2015; Kim et al., 2017), to study if 
Bace2 loss of function could change tumor cell proliferation/differentiation in a 
similar to fish melanophores and more importantly, if the changes in cell 
lineage lead to enhanced cell migration and invasion. We treated the ZMEL1 
cells with the Bace2 inhibitor PF-06663195, and found that inhibition of Bace2 
in ZMEL1 cells caused a dose-dependent dendritic phenotype (Figure 34A-B), 
one of the hallmarks for melanoma cells differentiation. ZMEL1 dendricity is 
measured both by an increase in cellular length-to-width ratio. Bace2 inhibition 
also leads to a significant increase in cell number (Figure 34C). This increase 
in cell number is consistent with an increase in proliferation as measured by a 
significant increase in phospho-histone H3 (pH3) staining (Figure 34D) but no 
change in apoptosis as measured by caspase 3/7 activity (Figure 34E). 
Collectively, these suggested that Bace2 loss of function induces ZMEL1 
differentiation (measured by changes in cell morphology) and proliferation, 
similar to what is seen in vivo during normal melanophores development. We 
further tested if the changes in cell lineage results in differences in cell 
migration. Using a transwell assay, we found that Bace2 inhibition leads to a 
strong increase in cell migration (Figure 34F), confirming our hypothesis that 
actively differentiating and proliferative cells still maintain a migratory capacity. 
 
To further study the effects of BACE2 on tumor progression, we crossed the 
bace2-/- mutant with the previously developed transgenic melanoma model 
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(mitfa:BRAFV600E; p53-/-) (Patton et al., 2005) , so that we can compare 
tumors derived from BACE2 WT or KO cells within a melanoma-prone 
background. bace2-/-; mitfa:BRAFV600E; p53-/- fish have an early melanoma 
onset (Figure 34G) and histologically a very aggressive tumor compared to 
bace2WT; mitfa:BRAFV600E; p53-/- sibling controls (Figure 34H). These 
together suggested that melanoma cells inherit the Bace2’s influence on 
melanocytes, and loss of Bace2 leads to an actively differentiating, highly 
proliferative cells which results in early tumor onset and tumor invasion in vivo.  
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Figure 34. Loss of Bace2 leads to elongated zebrafish melanoma cells 
which are highly invasive and proliferative. 
(A-C) The zebrafish melanoma cell line ZMEL1 was treated with 12.5μM or 
25μM of the Bace2 inhibitor PF-06663195 for 72 hours, and resulted in 
hyperdendritic cells (arrowhead) similar to what was seen in vivo. A 
representative field of cells is shown in (A) and dendricity is quantified as an 
increase in cell length to width ratio (B), along with an increase in overall cell 
number (C). Data are from three independent experiments, one-way ANOVA 
followed by Holm-Sidak's multiple comparisons test, ****P<0.0001.  
(D) The increased cell number induced by Bace2 inhibitor is due to increased 
ZMEL1 cell proliferation, as measured by increased phospho-histone H3 (pH3) 
immunostaining. Data are from three independent experiments, one-way 
ANOVA followed by Holm-Sidak's multiple comparisons test, ***P<0.001, 
****P<0.0001. 
(E) The increased cell number induced by Bace2 inhibitor is not due to 
changes in ZMEL1 apoptosis, as measured by caspase activity. Data are from 
three independent experiments, one-way ANOVA followed by Holm-Sidak's 
multiple comparisons test, ns=not significant. 
(F) ZMEL1 treated with 25μM of the Bace2 inhibitor PF-06663195 for 48 hours 
have increased migration in Transwell assay. Data are from five independent 
experiments, two-tailed t test, ***P<0.001.   
(G-H) Loss of Bace2 in zebrafish melanoma-prone background Tg(mitfa: 
BRAFV600E; p53-/-) leads to early onset tumor, with 62% of one-year-old adult 
developed melanoma. Those tumor are highly invasive as shown by histology 
H&E staining in (H). Chi-square test with Yate’s correction. All bar graphs are 
presented as mean ± s.e.m. Scale bars, 10μM. 
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3.2.3 Loss of BACE2 increases human melanoma cells invasion 
Given that the zebrafish model of melanoma greatly resembles human 
melanoma, and the BACE2 protein sequence is highly conserved between 
zebrafish and human, we wish to validate our zebrafish studies in human 
melanoma. Because our preliminary data suggest that loss of Bace2 induces 
melanocyte differentiation in zebrafish, we hypothesize that BACE2 loss of 
functions will lead to more differentiated/proliferative, and invasive melanoma 
cells. 
          
We generated a doxycycline-inducible lentiviral construct (Fellmann et al., 
2013) to knockdown BACE2 and transduced this construct into human 
melanoma cell line A375. Upon addition of doxycycline, GFP is co-expressed 
with an shRNA targeting BACE2 or luciferase (negative control). We confirmed 
efficient BACE2 knockdown using Western blot analysis (Figure 35A) and 
measured cell proliferation and cell invasion. Interestly, BACE2 knockdown did 
not alter cell proliferation the same way in zebrafish (data not shown) but both 
shRNAs had significant increases in matrix degradation consistent with 
increased invasion (Figure 35B-C). Taken together, these data indicated that 
Bace2 deficiency leads to melanoma cells with increased migratory and 
invasive capacity. 
 
The discrepancy in cell proliferation between zebrafish melanoma cells and 
human melanoma cells is unknown but likely to be real, as other human 
melanoma cell lines (SKMEL-28, MNT-1, MALME-3, MeWo) do not change 
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their proliferation behavior as well in response to BACE2 knockout, BACE2 
knockdown or BACE2 inhibition (data not shown). 
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Figure 35. BACE2 Knockdown results in invasive human melanoma 
cells.  
(A) Western blot analysis of BACE2 shRNA knockdown in A375 cells. 
Membrane probed with anti-BACE2 antibody and ß actin as loading control.  
(B) Knockdown of BACE2 in A375 led to increased invasion as measured 
through degradation of a collagen I/gelatin matrix. Top panel, cells expressing 
doxycycline-induced GFP. Bottom panel: representative matrix degradation 
(black spots with arrowhead).   
(C) Quantification of degradation area / cell (μm2). Data are from three 
independent experiments, > 90 fields analyzed per condition, Mann-Whitney 
test, **P<0.01, ****P< 0.0001.  All bar graphs are presented as mean ± s.e.m. 
Scale bar,10μM. 
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3.3 Discussion 
Melanoma is highly invasive tumor type and once metastatic it becomes 
extremely deadly. Previous literature provides evidence that suggested that 
cellular differentiation has a significant impact on the ability of melanoma cells 
to invade: while de-differentiated and neural crest like (MITF-low) cells are 
more invasive, partially differentiated cells (MITF-high) are more proliferative; 
and terminal differentiated cells are the least motile and become quiescent 
(Goding, 2011). A key question remaining in the melanoma metastasis field is 
how do the slow dividing, invasive pioneer melanoma cells resume 
proliferation once they land on a new site? Recently Kim et al proposed an 
alternative strategy that metastatic melanoma cells acquire differentiation after 
initial invasion and couple differentiation and proliferation to populate their 
number post seeding. This cell identity changes are under the regulation of 
microenvironmental morphogen endothelin, where endothelin induces a 
differentiated/proliferative state (Kim et al., 2017).  
 
While this solved the limited cell number dilemma for micro-metastasis, it did 
not address if the resulting differentiated/proliferative cells still maintain their 
invasion capacity. It is also possible that a macro-metastasis could reach out 
to form a secondary metastasis (Rashidi et al., 2000). Whether the macro-
metastasis cells undergo dedifferentiation to re-acquire invasion capacity, or 
themselves still maintain a migratory ability is poorly understood. In zebrafish 
both melanoblast and partially differentiating melanophores are highly 
migratory (Eom et al., 2012; Williams et al., 2018) also suggested that invasion 
is not uniquely linked to de-differentiated cells. bace2 null melanophores in 
zebrafish are both highly proliferative and actively differentiating melanophores 
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and still migratory to ectopic sites, suggesting that differentiated/proliferative 
melanoma cells can still maintain their invasion capacity.  
 
Our work shows that Bace2 loss of function in melanoma phenocopies 
melanocytes in a way that cells are still dendritic (a hallmark for differentiation) 
and proliferative (in the case of ZMEL1), and importantly the resulting 
melanoma cells are migratory, invasive and give rise to early tumor onset. This 
suggested that invasiveness is not solely linked to de-differentiated neural 
crest-like cells, and that actively differentiating and dividing cells still maintain 
invasion capacity. Our data would imply that solely targeting undifferentiated 
cell populations is likely to miss important players in metastasis, and 
maintaining BACE2 activity in melanoma is essential to push melanoma cells 
into terminal differentiation. Currently, BACE inhibitors (which mainly target 
BACE1 with some extent of BACE2 inhibition activity) are under clinical 
investigation for diseases such as Alzheimer’s (Lopez Lopez et al., 2017; 
Mandal et al., 2016; Vassar, 2014). Our work would suggest that we should be 
cautious using inhibitors that against BACE2 as this would prevent terminal 
differentiation of melanocytes, expand the actively differentiating population 
and increase the risk for neoplastic transformation.  
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CHAPTER 4: CONCLUSION AND FUTURE DIRECTIONS  
4.1 General conclusions and summary  
Proper patterning of pigment cells is important for animals for mate selection, 
hiding from predators and protection against UV induced DNA damage. To 
achieve this, animals have developed a highly organized and evolutionarily 
conserved system to regulate pigment cell behavior. Pigmentation is also a 
versatile system as they change in response to environmental needs. 
Mammalian melanocytes transfer melanin to surrounding keratinocytes to 
protect the epithelial keratinocytes from UV-damaged (Boissy, 2003). In 
contrast, zebrafish, a specifies rarely exposed to direct sunlight,  do not 
transfer melanin between cells but instead contract or aggregate 
melanosomes within melanophores to change their overall appearance very 
quickly during camouflage (Richardson et al., 2008; Sheets et al., 2007).  
 
The purpose of this dissertation is to describe how the sheddase Bace2 
coordinates with long range hormones to regulate melanophore cell behavior, 
and if these changes in melanophores have a consequence in malignancy. 
We first characterized all the cell behavior changes caused by Bace2 loss of 
function: wanderlust mutant melanophores acquire a dendritic cell morphology 
(a hallmark for differentiation) and actively divide, leading to ectopic migratory 
cells landing outside of the normal stripe. We next looked for the mechanism 
underlying this using a chemical suppressor screen, to look for drugs that can 
rescue this abnormality, ie. to convert a wanderlust phenotype into a WT.. It 
turned out that bace2 loss leads to hyperactivated PI3K/mTOR signaling, 
supported by the evidence that the abnormal melanophores can be rescued 
using PI3K/mTOR inhibitors. Finally, we examined the cause of this 
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hyperactivated PI3K/mTOR signaling and showed that Bace2 as a sheddase 
that cleaves the insulin receptor on melanophores and dampens melanophore 
sensitivity to the circulating ligand insulin b. When Bace2 is absent, the insulin 
receptor is intact and downstream PI3K/mTOR is activated in the presence of 
ligand.  
 
We showed how a melanophore-specific sheddase can negatively regulate 
insulin receptor on melanophores by proteolytic cleavage, and that the extent 
of intact insulin receptor is vital for melanophore morphology, proliferation and 
migration through PI3K/mTOR signal transduction. Similar to the aberrant 
embryonic melanophores, melanoma cells are also dendritic, proliferative and 
invasive when BACE2 is lost, but whether BACE2 utilizes the same 
mechanism of cleaving the insulin receptor in melanoma cells remains to be 
tested. 
 
4.2 Future directions 
4.2.1 How Bace2 itself is regulated 
We dissected the downstream effectors of Bace2 but a remaining question is 
how Bace2 itself is regulated. We examined bace2 expression across 
developmental stages using the Sanger developmental RNA-seq analysis. 
This demonstrated that bace2 is expressed at high levels at the zygote stage, 
consistent with maternal deposition. It then drops to low levels over the next 
20 hours and begins to rise again around 25 somites and further increases up 
until 72hpf (Figure 36). This raised the hypothesis that bace2 is regulated by 
melanophore-specific transcription factors. To assess this, we examined 
recently published data from Robert Cornell’s group (Seberg et al., 2017), 
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where they used both ChIP-seq and transcriptomics to identify downstream 
targets of Mitf and Tfap2a. Although not specifically highlighted in their 
manuscript, in a personal communication to us, they indicated that their data is 
consistent with bace2 being a likely direct transcriptional target of Tfap2a. 
Given our ongoing interest in bace2 biology, we hope to perform future 
analysis of the bace2 promoter to functionally dissect these regulatory 
elements.  
 
Figure 36. bace2 expression in zebrafish embryos. bace2 is maternally 
deposited at early development (from zygote to blastula dome) and then 
reactivated between prim-5 (24hpf) to 5dpf in WT embryos. Data is adapted 
from Sanger developmental RNA-seq analysis.  
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Insulin signaling has multiple negative feedback mechanism to titrate down 
excessive signaling. Insulin is known to induce insulin receptor internalization 
to decrease the number of insulin receptors on the plasma membrane (Di 
Guglielmo et al., 1998). Activated mTORC1/S6K signaling inhibits IRS-1 
function (Rozengurt et al., 2014). We propose that Bace2 activity can also be 
regulated by a feedback loop within Insulin/PI3K/mTOR signaling. Excessive 
PI3K/mTOR caused by Bace2 low might trigger a transcriptional or post-
translational activation of Bace2 to restore Bace2 activity.  
     
4.2.2 How PI3K/mTOR regulates dendrite formation 
We showed that activated PI3K/mTOR leads to dendritic melanophore 
morphology, but did not provide a mechanistic explanation. PI3K/mTOR 
signaling is well known to affect cytoskeleton arrangement and change neuron 
axon and dendrite patterning, in which PI3K signaling regulates downstream 
Rac/CDC42 signaling to drive dendrite neuronal morphology (Angliker and 
Rüegg, 2013; Jacinto et al., 2004; Liu et al., 2010; Sarbassov et al., 2004). We 
hypothesize that a similar mechanism is utilized in melanophore dendrites 
since they are also regulated by small GTP-binding proteins such as Rac and 
Rho, through a fine-tuned balance between Rho (which stimulates dendrite 
retraction) and Rac (which stimulates dendrite formation) (Scott, 2002). In the 
future, we would like to test if wanderlust mutants have excessive Rac 
GTPase activity because of hyperactivated PI3K/mTOR.   
 
4.2.3 The source and other functions of insulin b ligand in zebrafish 
Because of a genome duplication in zebrafish, zebrafish have two insulins. 
Insulin A is similar to pancreatic insulin in mammals and is responsible for 
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glucose homeostasis, but the source and function of insulin b is less 
understood (Papasani et al., 2006). Our work implies that insulin B is 
maternally deposited during early embryogenesis and then zygotically 
expressed in the head/brain region between 48hpf and 72hpf. CNS expressed 
insulin is seen in multiple organisms including not only zebrafish but also 
Drosophila (Gray et al., 2014; Luo et al., 2012), where they are believed to 
have functions in the CNS and so may have functions outside of glucose 
homeostasis (Deltour et al., 1993; Havrankova et al., 1978; Mehran et al., 
2012; Molnár et al., 2014). In subsequent studies, we hope to delineate the 
types of cells producing insulin B and the exact differences between Insb and 
these other insulins.  
      
4.2.4 How are other circulating factors regulated in a melanophore 
specific manner 
Melanocytes are known to be regulated by multiple hormones, such as thyroid 
hormone, sex hormones and α-MSH (McMenamin et al., 2014; Natale et al., 
2016; Spencer and Schallreuter, 2009). One remaining question is how are 
those general circulating hormones regulated in a cell-type specific manner 
and how do they coordinate with melanocyte differentiation states? Our work 
suggests a cleavage based mechanism where Bace2 cleaves and inactivates 
the insulin receptor to decrease sensitivity to circulating insulin. We 
hypothesize that cleavage based regulation is a generalized mechanism 
utilized by melanocytes to monitor their response to environmental factors. 
Sheddase availability could be regulated by a cell type specific transcription 
factor so that sheddases might act to connect cellular differentiation to the 
strength of ligand-induced signaling. Melanocytes are also expressing other 
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proteases such as ADAM-9 and ADAM-10 (Lee et al., 2010a; Zigrino et al., 
2005). It is therefore intriguing to test if the network of sheddases within 
melanophores could cleave their own RTKs or GPCRs to fine-tune 
downstream signalings.  
 
4.2.5 Mechanistic study of the roles of BACE2 in melanoma 
We showed in Chapter 3 that melanoma cells respond to BACE2 loss in a 
similar manner to melanocytes, but failed to provide further mechanistic 
studies. In future, we would like to test if BACE2 cleaves the insulin receptor in 
human melanoma cells, and changes downstream PI3K/mTOR activity. We 
predict that Bace2 null melanoma cells would also have hyperactivated 
PI3K/mTOR in mammalian system and become addicted to this for survival. 
BACE2 is deleted in a small percentage of human melanoma patients and 
PI3K/mTOR inhibitors are likely to be very efficacious in this context.  
 
Furthermore, humans only have pancreatic derived insulin. Our research 
showed that zebrafish insulin b alters melanocyte behavior. Accordingly, 
people with a rare disease of excess insulin secretion called acanthosis 
nigricans sometimes develop striking changes in skin pigmentation 
(Hermanns-Lê et al., 2004). We would like to investigate the roles of 
pancreatic insulin in promoting melanoma progression in the future.  
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CHAPTER 5: MATERIALS AND METHODS    
5.1 Experimental model and subject details 
Zebrafish 
Fish Husbandry: 
Fish stocks were reared under standard conditions at 28.5°C under 14:10 
light:dark cycles. Healthy, immune-competent male and female adults of the 
AB strain were used for breeding (animals were typically ~8 months when 
bred). Animals were fed standard zebrafish diet consisting of brine shrimp 
followed by Zeigler pellets. For all mutant studies, we compared bace2-/- 
siblings to AB siblings derived from an initial incross of the AB and bace2-/- 
strain. Sex determination in embryos is not possible at the stages used in this 
study. Embryos were collected from natural mating and incubated in E3 buffer 
(5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM MgSO4) at 28.5°C. The 
bace2-/- fish were obtained from the Wellcome Trust Sanger Institute. 
  
Transgenic lines: 
One-cell-stage bace2-/- embryos were injected with the given DNA construct 
Tg(fugu dct: Z-bace2; cryaa: YFP) at 25 ng/μl with Tol2 mRNA at 20 ng/μl. 
Embryos were screened at 3 days post fertilization for the presence of yellow 
fluorescent protein (YFP) in the eye lens. YFP positive embryos were grown to 
adulthood and outcrossed so as to identify founders that gave germline 
transmission. To quantify melanophores rescue, founders were outcrossed to 
bace2-/- and the F1 were screened for melanophores rescue and the presence 
of YFP positive lenses. 
One-cell-stage bace2-/- embryos were injected with the given DNA construct 
Tg(fugu tyrp1:dnIRS2-EGFP; cmlc2: mCherry) at 25 ng/μl with Tol2 mRNA at 
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20 ng/μl.  Embryos were screened at 30hpf for the presence of mCherry in the 
heart. dnIRS2(Ye et al., 2016) is a previously published dominant negative 
insulin receptor substrate 2 that non-productively binds to the insulin receptor 
to inhibit insulin signaling.             
Tg(tyrp1b:membrane-mCherry) and Tg(mitfa:EGFP) fish strains were 
generous gifts from Dr. David Parichy and Dr. James Lister respectively. 
bace2-/- was crossed into these strains to generate bace2-/-; 
Tg(tyrp1b:membrane-mCherry) and bace2-/-; Tg(mitfa:EGFP). 
  
Cell Lines 
The ZMEL1 cell line(Heilmann et al., 2015), A375 cell line and HEK 293T cell 
line were maintained as previously described. All cells were cultured in DMEM 
with 10% FBS/penicillin/streptomycin/glutamine. The sex of the animal from 
which the ZMEL1 line was derived is unknown. HEK 293T cells are derived 
from a female fetus. 
  
5.2 Method details 
Genotyping of bace2-/- Fish 
Tail clips from adult zebrafish were placed in microcentrifuge tubes or thermal 
cycler plates containing 50μl of 50 mM NaOH. Samples were boiled at 95℃ for 
30min, then cooled down with 5μl of 1M Tris-HCL (pH=8.0). A 1:10 dilution of 
the supernatant was used in PCR. Primer sequences for PCR are listed in 
Table S2. DNA was PCR amplified with Promega GoTag green mastermix and 
digested using Hpy188I enzyme (NEB catalog # R0617S). Limit Hpy188I 
digestion time to one hour to avoid non-specific digestion (star activity). bace2-
/- confers a C to A mutation which abolishes the Hpy188I digestion site. WT 
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fish have two bands at 450bp and 240bp, bace2-/- fish have one band at 
690bp, bace2+/- fish have three bands at 240bp, 450bp and 690bp. 
  
Chemical Screen 
The chemical screen was performed similar to prior publications (Kaufman et 
al., 2009). We aimed to identify suppressors of the bace2-/- melanophores 
phenotype by treating bace2-/- embryos from 24hpf to 72hpf with 30μM 
chemicals from Sigma LOPAC 1280 library. Chemicals were prepared from 
10mM stock and diluted into 30μM in 300μl E3 with 0.3% (v/v) DMSO. 
Embryos were staged at both shield stage and 24hpf prior to drug treatment.  
Three embryos per well in 48-well-plates were scored. Eight DMSO-only wells 
were included in each plate as negative control. Plates were foil wrapped to 
protect from light and incubated at 28.5℃ from 24hpf to 72hpf. At 72hpf, 
embryos were anaesthetized with tricaine and were subject to direct 
observation under light microscope. Melanophores rescue was scored from 0-
5, with 0 to be mutant-like melanophores (i.e. no rescue) and 5 to be 
completely rescued into WT-like melanophores. Chemicals with scores >3 
were subject to a second round of validation, with different aliquots of the 
library. Positive hits were ordered from Sigma and were tested for minimal 
concentration required to rescue bace2-/- phenotype. 
  
Embryo Drug Treatment 
Embryos were treated with the following chemicals (with working 
concentration, treatment time and catalog number). All chemicals are 
dissolved in DMSO. 
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PF-06663195 (Bace2 inhibitor): 100μM, various treating time (Sigma, catalog 
# PZ0262). 
AS605240: 110nM, 24hpf-72hpf (Sigma, catalog # A0233) 
Wortmannin: 230nM, 24hpf-72hpf (Sigma, catalog # W1628) 
LY-294,002: 15μM, 24hpf-72hpf (Sigma, catalog # L9908) 
Temsirolimus: 30μM, 24hpf-72hpf (Sigma, catalog # PZ0020) 
PP242: 15μM, 24hpf-72hpf (Abcam, catalog # ab141405) 
BMS-754807: 7.5μM, 24hpf-72hpf (Sigma, catalog # BM0003) 
NVP-AEW541: 60μM, 24hpf-72hpf (Selleck Chemicals, catalog # S1034) 
PTU: 300μM, 3dpF-5dpF (Sigma, catalog # P7629). 
  
Morpholino Injections 
All the morpholino oligonucleotides (MO) were synthesized by Gene ToolsTM 
LLC, resuspended in sterile water at a concentration of 1mM stock. MO stock 
was further diluted into working concentrations in sterile water and injected 
into zebrafish embryos at the one-cell stage by microinjection, at 
~1.5nL/embryo. MO working concentration, sequence and reference 
information are listed in Table S1. 
The efficacy of splicing morpholinos below have been confirmed using 
Reverse transcription PCR (RT-PCR), with primer information listed in Table 
S2. 
The efficacy of mTOR splicing MO has been also confirmed using WB, with 
primary antibody: mTOR (7C10) Rabbit mAb (Cell Signaling Technology, 
catalog # 2983S). The efficacy of Insulin receptor ATG MO has been 
confirmed using WB, with primary antibody: insulin R β (C-19) (Santa Cruz 
Biotechnology, catalog # sc-711). The efficacy of Pdx1 and Hb9 ATG MO 
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have been confirmed indirectly using immunostaining against Insulin protein, 
with primary antibody: insulin (Genetex, catalog # GTX128490). 
  
Measurement of Tailfin Melanophore Cell Area 
The extent of melanophore dendricity in the tailfin was calculated as the area 
of melanophores covering the tailfin mesenchyme. This was quantified by 
thresholding the mCherry intensity or thresholding the bright field intensity to 
highlight the pixels that represent melanophores in each image, and 
measuring the area they cover with FIJI software. 
  
ZMEL1 phospho-Histone H3 (pH3) Immunostaining 
ZMEL1 were seeded at 6000 cells/well in white wall, clear bottom 96-well 
plates (Fisher Scientific, catalog # 07-200-566) in DMEM/10% FBS/ 
penicillin/streptomycin/glutamine. The cells were allowed to adhere overnight, 
and then media were changed to Bace2 inhibitor (PF-06663195) containing 
media at 12.5μM or 25μM with 0.025% (v/v) DMSO. Cells were grown for a 
total of 3 days after the addition of Bace2 inhibitor. At the end of the treatment, 
the cells were fixed with paraformaldehyde (4% in 1X PBS), permeabilized 
with 0.1% Triton-X-100 for 15 min at room temperature. Cells were rinsed with 
1X PBS three times and then blocked with 1X PBS/5% goat serum/0.3% 
Triton X-100 for 1 hour at room temperature, and then stained with anti-pH3 
primary antibody (1:1000, EMD Millipore, catalog # 05-806) diluted in antibody 
dilution buffer (1X PBS/1% BSA/0.3% Triton X-100) at 4℃ overnight. Cells 
were rinsed with 1X PBS three times the next day and then stained with anti-
mouse Alexa 647 (1:1000, CST, catalog # 4410) diluted in antibody dilution 
buffer for 1 hour at room temperature in the dark. Cells were rinsed three 
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times with 1X PBS and stained with Hoechst 33342 (4μg/ml, Thermo Fisher 
Scientific, catalog # H3570) for 30 min at room temperature in the dark. Cells 
were rinsed three times with 1X PBS and imaged using a GE INCell 6000. 6 
fields were captured per well using a Nikon 10X Plan Apo objective, 0.45NA. 
Images of the Hoechst signal was captured via the DAPI channel in order to 
identify the nucleus. The pH3 was captured via the far-red channel to identify 
the mitotic cells. The image analysis script was performed within the Perkin 
Elmer Columbus software. Percentage of mitotic cells were quantified by 
calculating pH3 positive cells as a fraction of the total number of cells in each 
well. 
  
RT-PCR 
Zebrafish embryos were homogenized in 1ml of Trizol (Life Technologies, 
catalog #15596 - 018) on ice using Bel-Art micro-tube homogenizer (Fisher 
Scientific, catalog # 03-421-215) for one minute, with a pool of 5 to 50 
embryos at 3dpF. Then total RNA from zebrafish embryos were extracted 
using Direct-zol RNA miniprep kit (Zymo Research, catalog # R2050). cDNA 
library was constructed using SuperScript III First-Strand kit (Thermo Fisher 
Scientific, catalog # 18080-400). cDNA from both the control embryos and the 
morpholino injected embryos were used in downstream PCR  
reaction to confirm the efficacy of morpholino knockdown. 
 
Knockdown of BACE2 in A375 Human Melanoma Cell Line 
shRNAs were designed and constructed following(Fellmann et al., 2013). 97-
mer oligonucleotides coding for six shRNAs against human BACE2 (see 
sequence below) were PCR amplified using the primers miRE-Xho-fw (5’- 
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TGAACTCGAGAAGGTATAT TGCTGTTGACAGTGAGCG-3’) and miRE-
EcoOligo-rev (5’-TCTCGAATTCT AGCCCCTTGAAGTCCGAGGCAGTAGGC-
3’ ), 0.05 ng oligonucleotide template, and the PfuUltra HF kit (Agilent), and 
cloned into miRE LT3GEP1R (pRRL) Tet-On all-in-one vector. Lentiviral 
particles were produced in HEK 293T cell transfected with miRE shRNA 
lentiviral vector, psPAX2 packaging plasmid and pMD2.G envelope plasmid. 
A375 was transduced with lentiviral particles under single-copy conditions, and 
then selected with puromycin (1μg/ml) for around one week, until GFP positive 
cells were enriched for 90%. Post puromycin selection, 1μg/ml doxycycline 
were included in culture media for 5 days and the protein lysates were 
collected to measure shRNA knockdown efficiency. Control shRNA targeting 
Renilla luciferase and two shRNAs (bace2.1690: shRNA#1, bace2.1742: 
shRNA#2) with the best knockdown efficiency were included for downstream 
functional assay. All shRNA sequence are listed in Table 4.  
  
Cell Counting for Metamorphosis Zebrafish 
24dpF age matched and size matched siblings were treated with epinephrine 
to contract pigment granules and also treated with 4mg/ml tricaine before 
imaging. Fish were tile scanned (22μm z step) using an upright Zeiss 
Discovery V16 equipped with a motorized stage in brightfield. Images were 
acquired with the Zeiss Zen software v1. Ten somites from dorsal and ventral 
sides of one fish (start the first somite in the beginning of dorsal fin, and count 
posteriorly) were defined as region of interest (ROI). Two artificial lines were 
drawn parallel to the vertebrate and aligned their one ends to the tail fin. 
Region inside of the two lines are defined as intra-stripe region, as WT 
zebrafish form melanophores mainly inside of this region; region outside of the 
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two lines are defined as inter-stripe region. Inter-stripe melanophores reside 
within ROI were counted manually. 
 
in situ Hybridization (ISH) 
ISH were performed as described in(Thisse and Thisse, 2008). Embryos were 
fixed at 24hpf, 48hpf and 72hpf. Probes were diluted to a working solution of 
0.8 ng/μl. Staining time varied between probes from couple hours at room 
temperature, or overnight at 4℃. Fluorescent ISH (FISH) was performed as 
described in(Welten et al., 2006). In brief, post methanol fixation embryos are 
treated with 3% H2O2 in methanol for 20 min at room temperature to inhibit 
endogenous peroxidase activity. Then FISH follows the same procedure with 
regular ISH except those modifications: performing all hybridization and wash 
steps at 55℃ instead of 70℃,  with 0.25ng/μl for both insb antisense and sense 
probe. Dilute anti-DIG-POD antibody (1:2000, Sigma-Aldrich, catalog # 
11207733910) for anti-DIG-HRP detection in antibody buffer and pre-adsorb 
for 2 h at room temperature with slow agitation. Incubate embryos overnight in 
anti-DIG-POD antibody and next day wash 6 times for 15 minutes in PBST at 
room temperature. Dilute TSA Plus Cyanine 3 reagent (1:50, PerkinElmer, 
catalog # NEL744001KT) in the amplification buffer supplied and incubate 
embryos with diluted TSA/Cyanine 3 reagent for 30min at room temperature in 
the dark. Wash 8 times for 15 minutes in PBST and then image embryos. 
double FISH (dFISH) follows the same procedure with single probe FISH 
except for the following modifications. Hybridization at 65℃ with bace2 
riboprobe (3ng/μl) labelled with DIG (Sigma-Aldrich, catalog # 11277073910) 
and crestin riboprobe (2.92ng/μl) labelled with fluorescein (fluorescein-12-
UTP, Sigma-Aldrich, catalog # 11685619910) in hybridization mix (HM+) with 
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5% dextran sulfate (Sigma-Aldrich, catalog # D8906-5G) to allow two targets 
to be visualized simultaneously. Embryos were then incubated overnight at 
4°C with anti-DIG-AP antibody (1:5000, Sigma-Aldrich, catalog # 
11093274910) and anti-fluorescein-HRP antibody (1:500, Sigma-Aldrich, 
catalog # 11426346910) followed by extensive washes in PBST. To detect 
HRP (crestin), embryos were incubated with TSA Plus fluorescein evaluation 
kit (1:50, PerkinElmer, catalog # NEL741E001KT) for 30 min in the dark in 
amplification buffer. Following the addition of 0.001% H2O2 signal was allowed 
to develop for 30 min. After two washes with PBST, Fast Red (Sigma, catalog 
# F4648) was used according to the manufacturer’s instructions to detect the 
AP (bace2). The embryos were then extensively washed 4x15min in PBST, 
and DAPI was used as a nuclear counterstain. Mount embryos in low melting 
agarose for imaging acquisition. Tile scan images were collected with a Leica 
TCS SP5 II (DMI6000 CFS; acquisition software Leica Application Suite AF v. 
2.6.3.8173). Confocal images were acquired at 1,024 × 1,024 pixels (20.0-μm 
z step) using a 10X and 40X objectives, with zoom-in factor of 3 for 120X 
defection. The 3D reconstructions of the Insb, bace2 and crestin expression 
were performed using Imaris software. 
Dct(Kelsh et al., 2000), mitfa(Lister et al., 1999), tyr(Mellgren and Johnson, 
2004), sox10(Dutton et al., 2001), crestin(Luo et al., 2001) and c-kit(Parichy et 
al., 1999) probes were generous gifts from Dr. David Parichy. 
Pmela(Schonthaler et al., 2005), ednrb1a(Parichy et al., 2000) and 
foxd3(Odenthal and Nüsslein-Volhard, 1998) probes were generous gifts from 
Dr. James Lister. Tyrp1b probe DNA template was PCR amplified from MGC 
clone plasmid (Thermo Fisher Scientific, catalog # EDR1052-210947471), and 
in vitro transcribed using T3 RNA polymerase. 
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Bace2 probe DNA template was PCR amplified from plasmid pENTR-z-bace2, 
and in vitro transcribed using T3 RNA polymerase. 
Insa probe was validated by (Thisse, B., Thisse, C. (2004) Fast Release 
Clones: A High Throughput Expression Analysis. ZFIN Direct Data Submission 
(http://zfin.org).). Insa probe DNA template was PCR amplified from MGC 
clone plasmid (Dharmacon, catalog # MDR1734-202792960), and in vitro 
transcribed using T3 RNA polymerase. 
Insb probe was validated by(Junker et al., 2014). Insb probe DNA template 
was amplified from zebrafish cDNA library and then TOPO TA cloned into 
pCR™II-TOPO TA vector. The insb antisense probe was PCR amplified and 
then in vitro transcribed using T3 RNA polymerase. The insb sense probe 
(negative control) was digested with HindIII then in vitro transcribed using T7 
RNA polymerase. Primer sequence is listed in Table S2. Probe sequence, 
source and reference information is listed in Table S3. 
  
Embryos Protein Immunofluorescence 
Embryos were kept in 300μM PTU to inhibit melanin synthesis. Embryos were 
fixed with 4% paraformaldehyde in PBS overnight at 4°C, then dehydrated in 
100% methanol overnight at -20°C. Embryos were rehydrated with 50% 
methanol/PBS then into PBST (PBS with 0.1% Tween-20) for 5min each, then 
permeabilized with 100% acetone at -20°C for 12 min (for 24hpf embryos) or 
20 min (for 2-3dpf embryos). Embryos were blocked with blocking buffer 
(PBST+1%DMSO+4%BSA) for 1 hour at room temperature. Antibodies were 
diluted in blocking buffer, applied to embryos and incubated overnight at 4°C. 
Embryos were then washed with washing buffer (PBST+1%DMSO) twice 
every 15 minutes for 2 hours at room temperature. Embryos were Incubate 
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with secondary antibody in blocking buffer for 2 hours at room temperature in 
dark. Embryos were then washed with washing buffer twice every 15 minutes 
for 1 hours at room temperature. For insulin staining: yolk was manually 
dissected off to visualize insulin staining in pancreas. For pS6 staining: pS6 
signal co-localized with melanophores was measured to identify melanophore 
specific PI3K/mTOR activity. For 24hpf and 48hpf embryos, the transgenic 
mitfa: EGFP line was used to mark melanophores in EGFP. For 72hpf 
embryos, the transgenic tyrp1b: membrane-mCherry line was used to mark 
melanophores in mCherry. (This is because tyrp1b promoter is not on at 
24hpf, and mitfa promoter is off at 72hpf). Embryos were mounted on agarose 
plate for imaging acquisition. Primary antibody: rabbit anti-zebrafish insulin 
(1:200, Genetex, catalog # GTX128490), rabbit anti-phospho-S6 Ribosomal 
Protein (Ser240/244) (D68F8) (1:800, CST, catalog # 5364), mouse anti-GFP 
(1:500, abcam, catalog # ab1218), chicken anti-mCherry (1:1000, abcam, 
catalog # ab205402). Secondary antibodies: Alexa-Fluor 488 anti-rabbit 
(1:200, CST, catalog # 4412), Alexa-Fluor 594 anti-rabbit (1:200, CST, catalog 
# 8889), Alexa-Fluor 594 anti-chicken (1:200, abcam, catalog # ab150176), 
Alexa-Fluor 488 anti-mouse (1:200, CST, catalog # 4408). 
  
Creation of pmela CRISPR Mutant 
Creation of pmela CRISPR knockout mutant was adapted from(Gagnon et al., 
2014). Guide RNA (gRNA) was designed against the Pmela coding sequence, 
and synthesized via in vitro transcription. The gRNA was incubated with 
purified recombinant Cas9-3NLS protein (IDT, catalog # 1074181), and these 
were coinjected (300ng/μl gRNA+1μg/μl protein) into single cell zebrafish 
embryos, with 1.5nL injection volume per embryo. F0 embryos displayed 
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mosaic knockout phenotype similar to fading vision mutant(Schonthaler et al., 
2005), and were raised into adulthood. F0 founders were incrossed to yield 
trans-heterozygous F1 fish.  Pmela gRNA sequence is listed in the Key 
Resource Table. 
  
Insa Positive Cell Area Measurement 
Insa ISH pictures were used to measure the insa positive cell area. Insa 
positive cell area is quantified by thresholding the bright field intensity to 
highlight the pixels that represent insa in each image, and measuring the area 
they cover with FIJI software. 
  
High Content Cell Morphology Analysis 
High-content image analysis was used to measure the effects of 
pharmacological inhibition of Bace2 on ZMEL1 cell morphology. ZMEL1 were 
seeded at 4000 cells/well in black wall, clear bottom 96-well plates 
(PerkinElmer, catalog #6005182) in DMEM/10% FBS/ 
penicillin/streptomycin/glutamine. The cells were allowed to adhere overnight, 
and then media were changed to Bace2 inhibitor (PF-06663195) containing 
media at 12.5μM or 25μM with 0.025% (v/v) DMSO. Cells were grown for a 
total of 3 days after the addition of Bace2 inhibitor. At the end of the treatment, 
the cells were fixed with paraformaldehyde (4% in 1X PBS), permeabilized 
with 0.1% Triton-X-100 and stained using Hoechst 33342 (4μg/ml, Thermo 
Fisher Scientific, catalog # H3570) and HCS CellMask Deep Red Stain 
(1.7μg/ml, Thermo Fisher Scientific, catalog # H32721). Using a GE INCell 
6000, 6 fields were captured per well using a Nikon 10X Plan Apo objective, 
0.45NA. Images of the Hoechst signal was captured via the DAPI channel in 
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order to identify the nucleus. The HCS Cellmask Deep Red was captured via 
the far-red channel to identify the cell body. 
The image analysis script was performed within the Perkin Elmer Columbus 
software. Briefly the Hoechst stained nuclei was used to initially segment 
objects and act as a seed region to segment the cells stained with HCS 
CellMask Deep Red. Cell morphology is the primary readout of this high-
content assay and the primary cell morphology parameters used are length to 
width ratio. Cell length is defined as the maximum distance (in microns) 
between two points on the cell mask. Cell width is defined as the diameter of 
the largest circle that will fit within the cell or nuclear mask. 
  
Knockout insr in ZMEL1 
Alt-R CRISPR-Cas9 gRNAs against zebrafish insra and insrb were designed 
using CHOPCHOP website(Labun et al., 2016) and synthesized by IDT. The 
RNP complex containing gRNAs (11μM of each insra and insrb gRNA 
mixture), tracrRNA ATTO™ 550 (22μM, IDT, catalog # 1075928) guide 
complex and an S. pyogenes recombinant Cas9 endonuclease (18.3μM, IDT, 
catalog # 1074181) were prepared at room temperature following 
manufacturer's instruction. A non-target gRNA was included as negative 
control (22μM). The final complex (10μl RNP and 20μl of electroporation 
enhancer at 10.8μM) was nucleofected into 90μl cell suspension containing 8 
million ZMEL1 cells using NEON transfection system (100μl kit, Thermo fisher 
Scientific, catalog # MPK10096, pulse voltage: 1400, pulse width: 20 and 
pulse number: 2) and plated back to fibronectin-coated flask. The tracrRNA 
ATTO™ 550 labelled ZMEL1 cells with RFP and was used to FACS sort RFP+ 
cells 3 days post nucleofection. Genomic DNA and protein lysates were 
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extracted from sorted cells to assay mutations using Surveyor assay and 
protein using Western Blot respectively. For surveyor assay, insra and insrb 
genomic sequence adjacent to gRNA PAM sites were PCR amplified and then 
digested with surveyor nuclease (IDT, catalog # 706020). gRNA sequences 
are listed in the Key Resource Table. Primers for Surveyor PCR are listed in 
Table S2. 
  
Plasmid Construction and Cell Line Expression 
The following plasmids were constructed using the Gateway Tol2kit. 
Fugu dct: Z-bace2 (zebrafish bace2); cryaa: YFP 
Fugu tyrp1:dnIRS2-EGFP; cmlc2: mCherry 
CMV: Z-bace2-2a-GFP-394 
CMV: Z-bace2 enzymatic dead-2a-GFP-394 
CMV: Z-insra-Myc-394 
CMV: Z-insrb-Myc-394 
CMV: tdtomato-394 (used as vector control) 
Zebrafish Bace2 (Z-bace2) cDNA was amplified from WT embryos’ cDNA 
library and cloned into pENTR/D-TOPO vector. 
Zebrafish Bace2 enzymatic dead cDNA was constructed by site-mutagenesis 
of two conserved protease sites (aspartic acids) into alanines (D98A and 
D292A) respectively. 
Fugu tyrp1 promoter was a generous gift from(Zou et al., 2006). 
Zebrafish dnIRS2-GFP was a generous gift from(Ye et al., 2016) and then 
further cloned into pENTR/D-TOPO vector. 
Zebrafish insra and insrb cDNA was amplified from WT embryos’ cDNA library 
and cloned into pENTR/D-TOPO vector. 
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CMV: Z-pmela-FLAG was constructed by In-fusion cloning to clone Z-pmela 
cDNA into pCS2FLAG backbone (Addgene, catalog #16331). The FLAG tag 
was C-terminal fused to Z-pmela cDNA. Z-pmela cDNA was amplified from 
MGC clone plasmid (Open Biosystems, catalog # MDR1734-202779066). All 
primers are listed in Table S2. 
Lipofectamine 2000 (Life Technologies, catalog # 11668019) was used to 
overexpress plasmids in HEK 293T cells. 
  
Western Blot 
Cell lysates were collected using RIPA buffer (Thermo Fisher Scientific, 
catalog # 89901), with addition of 1X protease inhibitor (Thermo Fisher 
Scientific, catalog # 78430), 1X phosphatase Inhibitor (Fisher Scientific, 
catalog #78441) and 5mM EDTA. Proteins concentrations were measured with 
Bradford (Sigma-Aldrich, catalog # B6916) according to kit direction. Protein 
were mixed with 6X SDS loading dye (Boston BioProducts, catalog # BP-
111R) and boiled at 95℃ for 10min. Proteins were run on pre-made mini 
protean TGX gels (Bio-Rad). Gels were transferred using Turbo™ Mini 
Nitrocellulose Transfer Pack (Bio-Rad, catalog # 1704158). Membranes were 
blocked in 5% milk for 1 hour at room temperature prior to addition of primary 
antibody overnight at 4℃. Membranes were washed with 1X TBST (0.1% 
Tween 20) for 3x10min, then incubated with secondary antibody for 1 hour at 
room temperature. Membranes were washed with 1X TBST for 3x10min. 
Signals were developed using ECL prime (GE Healthcare, catalog # 
RPN2236). Primary antibodies used for Western blot are: mTOR (7C10) mAb 
(1:1000, CST, catalog # 2983S), insulin R β (C-19) (1:200, Santa Cruz 
Biotechnology, catalog # sc-711), c-MYC (1:1000, Santa Cruz Biotechnology, 
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catalog # sc-40), BACE2 F-12 (1:100, Santa Cruz Biotechnology, catalog #sc-
271286), FLAG (1:500, Sigma-Aldrich, catalog # F3165). Secondary 
antibodies were: rabbit anti-mouse IgG H&L (HRP) (1:10,000, Abcam, catalog 
# ab97046), goat anti-rabbit IgG H&L (HRP) (1:10,000, Abcam, catalog # 
ab97051). 
  
Transwell Assay 
1X105 ZMEL1 cells were seeded into 3.0μM transwell inserts (Corning catalog 
# 353492) in 500μl of culture media, in the presence or absence of 25μM 
Bace2 inhibitor PF-06663195 with 0.025% (v/v) DMSO. The receiving plates 
(Corning catalog # 353504) were filled with 500μl culture media, also in the 
presence or absence of 25μM Bace2 inhibitor. ZMEL1 were allowed to migrate 
for 48 hours, then sterile cotton swabs were used to gently clean the inside of 
each membrane 3 times. Hoechst 33342 were added to final concentration of 
4μg/ml to facilitate cell counting. Image five different 20X fields per well and 
quantify cell numbers by image analysis software FIJI. 
 
Gelatin Degradation Assays 
Coverslips were prepared as in; briefly, autoclaved coverslips were coated 
with AlexaFluor 546-labeled gelatin (1 mg/ml) and crosslinked with 0.5% 
glutaraldehyde (Sigma) in 1X PBS. A layer of collagen I (Corning) in DPBS 
(Corning, with calcium and magnesium) at 0.5 mg/ml was subsequently 
polymerized on top of the gelatin-coated coverslip for 4 hrs at 37°C. 25,000 
A375 melanoma cells were seeded directly onto the collagen I/gelatin mixed 
matrix-coated coverslips in DMEM supplemented with 10% 
FBS/penicillin/streptomycin/glutamine and 1μg/ml doxycycline overnight. Cells 
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were fixed with 4% paraformaldehyde (EMS) in 1X PBS, and stained with 
DAPI (Sigma) to localize cells. Images were acquired on a Leica DM5500B 
microscope with a 100X/1.4-0.7 NA HCX PL APO oil objective and a DFC345 
FX camera. Matrix degradation was quantified using ImageJ, as described 
previously.                           
  
5.3 Quantification and statistical analysis  
Statistical comparisons were performed with the aid of GraphPad PRISM 7 
and the statistical details including sample size can be found in the figure 
legends. A p value of >0.05 is not considered statistically significant. * 
indicates p<0.05, ** indicates p<0.01, *** indicates p<0.001 and **** indicates 
p<0.0001.      
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Table 1. morpholinos working concentration, sequence and reference 
information. 
MO Name Working 
conc. 
MO Sequence (5’-3’) Reference 
Bace2 splicing MO 0.16mM GTTACCACATAACATACCGTTTGTC This paper 
PI3K γ ATG MO 1mM CATCATCACTGGCTTGCTGTTCCAT (Li et al., 
2015) 
mTOR splicing MO 1mM GGTTTGACACATTACCCTGAGCATG (Makky et al., 
2007) 
Insra ATG MO 0.5mM CAAAGTCCGCAGCCGCATTTTGACC (Wan et al., 
2014) 
Insrb ATG MO 0.1mM TGTGTCCAGCCGCATTCTGCCTCGC (Wan et al., 
2014) 
Insa splicing MO 0.5mM CCTCTACTTGACTTTCTTACCCAGA (Ye et al., 
2016) 
Insb splicing MO 0.25mM AAGTTGGAGACGTTGCTCACCCAGC (Ye et al., 
2016) 
Pdx1 ATG MO 0.45mM GATAGTAATGCTCTTCCCGATTCAT (Kimmel et 
al., 2011) 
Hb9 ATG MO 0.45mM TTTTTAGATTTCTCCATCTGGCCCA (Kimmel et 
al., 2011) 
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Table 1 (Continued) 
PI3K α ATG MO 1mM GTCTTGGAGGCATGATTTGTAATCC (Li et al., 
2015)  
PI3K β ATG MO 1mM GCATGGCAGAGAACACACTGAAGCC (Li et al., 
2015)  
PI3K δ ATG MO 1mM GGCATCGTGCAGGAAAACTCATCTAC (Li et al., 
2015)  
Pmela ATG MO 0.1mM GAGGAAGATGAGAGATGTCCACATG (Schonthaler 
et al., 2005)  
Pmelb ATG MO 0.2mM GTAGAGAATAGCTTCATTGTGTCAC (Burgoyne et 
al., 2015)  
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Table 2. primer sequence. 
Primer Sequence (5’-3') 
bace2 genotype F1 TCCTTGTTGCAGTCTATCCCT 
bace2 genotype R1 GCACTTGAACTCCTCAGTTACA 
mTOR MO F1 GAGTTCATGTTCCTGCTG 
mTOR MO R1 CCATCCAATGTAGCATTGG 
Insa MO F1 CATTCCTCGCCTCTGCTTC 
Insa MO R1 GGAGAGCATTAAGGCCTGTG 
Insb MO F1 CAGACTCTGCTCACTCAGGAAA 
Insb MO R1 GCGTGTAATGGTCATTTATTGC 
Tyrp1b ISH F1  TGGATAACCGTATTACCGCC 
Tyrp1b ISH R1  CGCGCAATTAACCCTCACTAAAGCACTAGTCATACCAGGATC 
Bace2 ISH F2 CACCATGCGGCTCTACGGGCTACTG 
Bace2 ISH R2 CGCGCAATTAACCCTCACTAAAGAGTCACTCACTTGATGCGAT
GGCGCA 
Insa ISH F1 TGTACGGAAGTGTTACTTCTGCTC 
Insa ISH R1 GGATCCATTAACCCTCACTAAAGGGAAGGCCGCGACCTGCAG
CTC 
Insb TOPO F3 AGGTGTGGCTGTTGGTGAAT 
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Table 2 (Continued) 
Insb TOPO R3 CTGGCTGTTCAGCTGCAGTA 
Insb ISH F1 AGGTGTGGCTGTTGGTGAAT 
Insb ISH R1 GGATCCATTAACCCTCACTAAAGGGGAATTCGCCCTTCTGGCT
G 
Insra CRISPR F1 ATGTGACTCTGTGTTCTGTGCC 
Insra CRISPR R1 TGCAGAATGCTGATTAACCAAT 
Insrb CRISPR F1 GCCTATGCTCTCGTCTCACTCT 
Insrb CRISPR R1 CCCATGTGTTTCATTCTAGCTG 
bace2 pENTR/D-TOPO F1 CACCATGCGGCTCTACGGGCTACTG 
bace2 pENTR/D-TOPO R1 CTTGATGCGATGGCGCACCAAAGA 
insra pENTR/D-TOPO F1 CACCATGCGGCTGCGGACTTTGATT 
insra-pENTR/D-TOPO-R1 AGAAGGGGTGGATCGGGGTAGAG 
insrb pENTR/D-TOPO F1 CACCATGCGGCTGGACACATCTGTGG 
insr pENTR/D-TOPO R1 GGACGGACTAGATCTGGGTAAAGACAG 
pmela cDNA F1 CGATTTAAAGCTATGCACCATGTGGACATCTCTCATCTTCCT 
pmela cDNA R1 ATCATCCTTGTAATCCACCACGCGTCCCAGCAGAAGT 
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 Table 3. in situ hybridization (ISH) probes, source and reference. 
ISH probe Source Reference 
Dct Gift from David Parichy (University of Virginia) Kelsh et al., 2000 
Mitfa Gift from David Parichy (University of Virginia) Lister et al., 1999 
Tyr Gift from David Parichy (University of Virginia) Mellgren and Johnson, 
2004 
Sox10 Gift from David Parichy (University of Virginia) Dutton et al., 2001 
Crestin Gift from David Parichy (University of Virginia) Luo et al., 2001 
c-kit Gift from David Parichy (University of Virginia) Parichy et al., 1999 
Pmela Gift from James Lister 
(Virginia Commonwealth University) 
Schonthaler et al., 2005 
  
ednrb1a Gift from James Lister 
(Virginia Commonwealth University) 
Parichy et al., 2000 
  
Tyrp1b Thermo Fisher Scientific cat # EDR1052-210947471 
Bace2 This thesis   
Foxd3 Gift from James Lister 
(Virginia Commonwealth University) 
Odenthal and Nüsslein-
Volhard 1998 
Insa Dharmacon cat # MDR1734-
202792960 
Insb This thesis (Junker et al., 2014) 
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Table 4. shRNA sequence to knockdown BACE2 in human melanoma cell 
A375. 
 
shRNA Sequence (5’-3’) 
Renilla Luciferase 
(shRNA control) 
TGCTGTTGACAGTGAGCGCAGGAATTATAATGCTTATCTATAGTGAA
GCCACAGATGTATAGATAAGCATTATAATTCCTATGCCTACTGCCTC
GGA 
bace2.1690 
(shRNA #1) 
TGCTGTTGACAGTGAGCGATCAGACATCGCTGGAAATGAATAGTGA
AGCCACAGATGTATTCATTTCCAGCGATGTCTGACTGCCTACTGCC
TCGGA 
bace2.1742 
(shRNA #2) 
TGCTGTTGACAGTGAGCGATCAGCTATTAAGAAAATCACATAGTGA
AGCCACAGATGTATGTGATTTTCTTAATAGCTGAGTGCCTACTGCCT
CGGA 
bace2.1462 TGCTGTTGACAGTGAGCGACAGGTGCTGCAGTGTCTGAAATAGTGA
AGCCACAGATGTATTTCAGACACTGCAGCACCTGCTGCCTACTGCC
TCGGA 
bace2.2002 TGCTGTTGACAGTGAGCGATGCCACCAACATAAAACAAAATAGTGA
AGCCACAGATGTATTTTGTTTTATGTTGGTGGCACTGCCTACTGCCT
CGGA 
bace2.1891 TGCTGTTGACAGTGAGCGCTCCTCCCTACTTCCAAGAAAATAGTGA
AGCCACAGATGTATTTTCTTGGAAGTAGGGAGGATTGCCTACTGCC
TCGGA 
bace2.2006 TGCTGTTGACAGTGAGCGAACCAACATAAAACAAAACCAATAGTGA
AGCCACAGATGTATTGGTTTTGTTTTATGTTGGTGTGCCTACTGCCT
CGGA 
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